CA2399887C - Biosensor - Google Patents
Biosensor Download PDFInfo
- Publication number
- CA2399887C CA2399887C CA002399887A CA2399887A CA2399887C CA 2399887 C CA2399887 C CA 2399887C CA 002399887 A CA002399887 A CA 002399887A CA 2399887 A CA2399887 A CA 2399887A CA 2399887 C CA2399887 C CA 2399887C
- Authority
- CA
- Canada
- Prior art keywords
- biosensor
- code pattern
- substrate
- electrodes
- electrically conductive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
- G01N33/5438—Electrodes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/4875—Details of handling test elements, e.g. dispensing or storage, not specific to a particular test method
- G01N33/48771—Coding of information, e.g. calibration data, lot number
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/00584—Control arrangements for automatic analysers
- G01N35/00722—Communications; Identification
- G01N35/00732—Identification of carriers, materials or components in automatic analysers
- G01N2035/00792—Type of components bearing the codes, other than sample carriers
- G01N2035/00811—Type of components bearing the codes, other than sample carriers consumable or exchangeable components other than sample carriers, e.g. detectors, flow cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
- G01N27/3272—Test elements therefor, i.e. disposable laminated substrates with electrodes, reagent and channels
Abstract
The present invention relates to a biosensor. The biosensor includes a support substrate, an electrically conductive coating positioned on the support substrate, the coating being formed to define electrodes and a code pattern, wherein there is sufficient contrast between the conductive coating and the substrate such that the code pattern is discernible, and a cover cooperating with the support substrate to define a channel. At least a portion of the electrodes are positioned in the channel.
Description
BIOSENSOR
FIELD OF THE INVENTION
The present invention relates to a biosensor, more particularly to an electrochemical biosensor with a code pattern thereon.
BACKGROUND AND SUMMARY OF THE INVENTION
Electrochemical biosensors are known. They have been used to determine the concentration of various analytes from biological samples, particularly from blood.
Electrochemical biosensors are described in U.S. Patent Nos. 5,413,690; 5,762,770; 5,798,031;
and 5,997,817.
It is also known to include a code on a test strip that identifies the manufacturing batch of the strip. See WO 99122236.
According to one aspect of the present invention a biosensor is provided. The biosensor comprises a support substrate, an electrically conductive coating positioned on the support substrate, the coating being formed to define electrodes and a code pattern, wherein there is sufficient contrast between the conductive coating and the substrate such that the code pattern is discernible, and at least one reagent positioned on at least one electrode.
According to another aspect of the present invention a biosensor is provided.
The biosensor comprises a support substrate, an electrically conductive coating positioned on the support substrate, the coating being formed to define electrodes and a code pattern, wherein there is sufficient contrast between the conductive coating and the substrate such that the code pattern is discernible, and a cover cooperating with the support substrate to define a channel. At least a portion of the electrodes are positioned in the channel.
In addition, a method of forming a biosensor is provided in accordance with the present invention. The method comprises the steps of providing a substrate coated with an electrically conductive material, ablating the electrically conductive material to form electrodes and a code pattern, wherein there is sufficient contrast between the conductive coating and the substrate such that the code pattern is discernible, and applying a reagent to at least one of the electrodes.
Still further, in accordance with the present invention a biosensor is provided. The biosensor comprises a support substrate and an electrically conductive coating positioned on the support substrate. The coating is formed to define electrodes and means for identifying the biosensor, wherein there is sufficient contrast between the conductive coating and the substrate such that the identifying means is discernible.
Additional features of the invention will become apparent to those skilled in the art upon consideration of the following detailed description of the preferred embodiment exemplifying the best mode of carrying out the invention as presently perceived.
BRIEF DESCRIPTION OF THE DRAWINGS
The detailed description particularly refers to the accompanying figures in which:
Fig. 1 is a perspective view of a biosensor in accordance with the present invention, showing the biosensor formed to include a code pattern formed thereon.
Fig. 2 is an exploded assembly view of the biosensor of Fig. 1, showing the biosensor including an electrode array positioned at one end, a spacer substrate including a notch, and a cover formed to extend over a portion of the notch.
Fig. 3 is a view taken along lines 3-3 of Fig. 1.
Fig. 4 is a view taken along lines 4-4 of Fig. 1.
Fig. 5 is an enlarged top view of an alternative code pattern formed on a biosensor in accordance with the present invention.
Fig. 6 is an enlarged tap view of an alternative code pattern formed on a biosensor in accordance with the present invention.
DETAILED DESCRIPTION OF THE INVENTION
The present invention relates to a biosensor and a method for manufacturing a biosensor that has a specific code pattern. This code pattern is beneficially formed from the same electrically conductive material and in the same manner as the electrodes of the biosensor, which reduces steps in the manufacturing process. Laser ablation is preferably used in forming the code pattern while generating the electrode pattern. The code pattern can be read in a number of ways, non-limiting examples of which include optically or electrically depending on the structures formed onto the biosensor. The structures could show contrast in their optical reflectivity, their electrical conductivity, or their resistance respectively.
The structures could also be high reflectivity areas surrounded by low reflectivity areas or vice versa, or areas of high electrical conductivity surrounded by areas of low conductivity. Aspects of the invention are presented in Figs. 1-6, which are not drawn to scale and wherein like components in the several views are numbered alike.
Figs. 1-4 illustrate an aspect of the invention in the form of a biosensor 10 having an electrode-support substrate 12, an electrical conductor 13 positioned on the substrate 12 that is disrupted to define electrodes 14, 16, a spacer substrate 18 positioned on substrate 12, and a cover substrate 20 positioned on the spacer substrate 18. Biosensor 10 is preferably rectangular in shape. It is appreciated however, that biosensor 10 can assume any number of shapes in accordance with this disclosure. Biosensor 10 is preferably produced from rolls of material however, it is understood that biosensor 10 can be constructed from individual sheets in accordance with this disclosure. Thus, the selection of materials for the construction of biosensor 10 necessitates the use of materials that are sufficiently flexible for roll processing, but which are still rigid enough to give a useful stiffness to finished biosensor 10.
Referring to Fig. 4, the support substrate 12 includes a first surface 22 facing the spacer substrate 18 and a second surface 24. In addition, as shown in Fig. 2, substrate 12 has opposite first and second ends 26, 28 and opposite edges 30, 32 extending between the first and second ends 26, 28. Substrate 12 is generally rectangular in shape, it is appreciated however, that support may be formed in a variety of shapes and sizes in accordance with this disclosure.
Substrate 12 is formed of a flexible polymer and preferably from a flexible polymer and preferably from a polymer such as a polyester or polyimide, polyethylene naphthalate (PEN).
A non-limiting example of a suitable PEN is 5 mil ( 125 um) thick KALADEX~, a PEN film commercially available from E.I. DuPont de Nemours, Wilmington, Delaware, which is coated with gold by ROWO Coating, Henbolzhelm, Germany.
Electrodes 14, 16 are created or isolated from conductor 13 on first surface 22 of substrate 12.
Non-limiting examples of a suitable electrical conductor 13 include aluminum, carbon (such as graphite), cobalt, copper, gallium, gold, indium, iridium, iron, lead, magnesium, mercury (as an amalgam), nickel, niobium, osmium, palladium, platinum, rhenium, rhodium, selenium, silicon (such as highly doped polycrystalline silicon), silver, tantalum, tin, titanium, tungsten, uranium, vanadium, zinc, zirconium, mixtures thereof, and alloys, oxides, or metallic compounds of these elements. Preferably, electrical conductor 13 is selected from the following materials: gold, platinum, palladium, iridium, or alloys of these metals, since such noble metals and their alloys are unreactive in biological systems. Most preferably, electrical conductor 13 is gold.
Electrodes 14, 16 are isolated from the rest of the electrical conductor 13 by laser ablation.
See Fig. 4. Techniques for forming electrodes on a surface using laser ablation are known.
See, for example, U.S. Patent No. 6,662,439, entitled "LASER DEFINED FEATURES
FOR
PATTERNED LAMINATES AND ELECTRODE". Preferably, electrodes 14, 16 are created by removing the electrical conductor 13 from an area extending around the electrodes to form a gap of exposed support substrate 12. Therefore, electrodes 14, 16 are isolated from the rest of the electrically-conductive material on substrate 12 by a gap having a width of about 25 ~m to about 500 p,m, preferably the gap has a width of about 100 p,m to about 200 ~,m.
Alternatively, it is appreciated that electrodes 14, 16 may be created by laser ablation alone on substrate 12. It is appreciated that while laser ablation is the preferred method for forming electrodes 14, 16 given its precision and sensitivity, other techniques such as lamination, screen-printing, or photolithography may be used in accordance with this disclosure.
As shown in Fig. 2, electrodes 14, 16 cooperate with one another to define an electrode array 36. In addition, electrodes 14, 16 each include a contact 34 and a lead 38 extending between the contact 34 and the array 36. It is appreciated that the leads 38 extending from the array can be formed to have many lengths and extend to a variety of locations on the electrode-support substrate 12. It is appreciated that the configuration of the electrode array, the number of electrodes, as well as the spacing between the electrodes may vary in accordance with this disclosure and that a greater than one array may be formed as will be appreciated by one of skill in the art.
Refernng again to Figs. 2 and 3, a recess 35 is formed from the electrical conductor 13 by laser ablation using techniques as described above. Recess is created by removing the electrical conductor 13 to expose the first surface 22 of the support substrate 12 adjacent to the first end 26. It is appreciated that a portion of the first surface 22 may also be removed to form the recess 35 in accordance with this disclosure.
In addition, as shown in Figs. 1, 2, and 4, the discernible code pattern 40 is formed from the electrical conductor 13 by laser ablation using techniques as described above with reference to electrodes 14, 16. Specifically, the code pattern 40 is created by removing the electrical con-ductor 13 in a pre-defined pattern to expose the first surface 22 of the support substrate 12.
While pattern 40 is illustratively a barcode type pattern, it is appreciated that the pattern 40 S
can take on any number of shapes and patterns, non-limiting examples of which are shown in Figs. 5 and 6.
It is also appreciated that the pattern 40 can be provided in a human readable, optical readable, or electrical readable form in accordance with this disclosure. The structures could show contrast in their optical reflectivity, their electrical conductivity, or their resistivity respectively. To aid in contrasting the electrical conductivity of the code pattern 40, the electrical conductor 13 of the pattern 40 may be coated with a second conductive material (not shown) that is different from the electrical conductor 13. Non-limiting examples of the second conductive material include carbon and silver. It is appreciated, however, that a wide variety of materials may be coated on the electrical conductor 13 to change the electrical property of the code pattern 40.
It is also appreciated; electrodes 14, 16 could be formed from layers of electrically conductive materials having different colors, reflectivity, conductance, etc. Thus, the code pattern can be formed by removing a portion of the electrical conductor layers, leaving behind areas of high reflectivity surrounded by low reflectivity areas or vice versa, areas of high electrical conductivity surrounded by areas of low conductivity or vise versa. It is also possible to laser etch a code pattern that has a known resistance and this area can be read electrochemically to identify or recognize the code pattern. Moreover, it is appreciated that the code pattern can be a combination of any of the above readable forms in accordance with the present invention.
As shown in Fig. 4, the code pattern 40 is isolated from the rest of the electrically conductive material 13 on substrate 12 by gaps 42. Gaps 42 can have a wide variety of widths in accordance with this disclosure depending upon the specific use of the code pattern 40. Non-limiting examples of widths of the gaps include from about 1 ltm to about 1000 Vim.
Alternatively, it is appreciated that the code pattern 40 may be created by laser ablation alone on substrate 12. It is appreciated that while laser ablation is the preferred method for forming the code pattern 40 given its precision and sensitivity, other techniques such as lamination, screen-printing, or photolithography may be used in accordance with this disclosure.
The manufacturer of biosensor 10 may maintain a central database containing a set of code patterns, each of which uniquely identifies an individual biosensor, or batch of biosensors.
There may also be associated with each code pattern a set of calibration data for the biosensor 10. It is appreciated that the code patterns may be associated with any number of identification or data sets in accordance with the present invention.
Spacer substrate 18 of biosensor 10 includes an upper surface 44 and a lower surface 46 facing the substrate 12. In addition, the spacer substrate 18 includes opposite first and second ends 48, 50. First end 48 includes a notch 52, which is defined by a border 54. The border illustratively includes three generally linear sides. It is appreciated that the notch can take on a variety of shapes and sizes in accordance with this disclosure. When biosensor 10 is assembled, the border 54 extends about at least a portion of the array 36 so that the array 36 is at least partially exposed in the notch 52.
Spacer substrate 18 is formed of a flexible polymer and preferably from a flexible polymer and preferably from a polymer such as an adhesive coated polyethylene terephthalate (PET) polyester. A non-limiting example of a suitable PET is 3 mil (75 um) thick white PET film both sides of which are coated with a pressure-sensitive adhesive (Product #
ARcare 8877) commercially available from Adhesives Research, Inc. Glen Rock, Pennsylvania.
It is appreciated that spacer substrate 18 may be constructed of a variety of materials and may be coupled to the substrate 12 and the cover substrate 20 using a wide variety of commercially available adhesives, or by welding (heat or ultrasonic) when large portions of the surface 22 of the electrode support substrate 12 are exposed and not covered by electrical conductor 13.
The cover substrate 20 is coupled to the upper surface 44 of the spacer substrate 18. See Fig. 3.
The cover substrate 20 includes opposite first and second ends 56, 58. The cover substrate 20 is coupled to the spacer substrate 18 such that the first end 56 is spaced-apart from the end 48 of the spacer substrate 18 and the second end 58 is spaced-apart from the end 50 of the spacer substrate 18. When biosensor 10 is assembled, cover substrate 20 cooperates with the spacer support 20 and the electrode-support 12 to define a capillary channel 60.
Cover substrate 20 is generally rectangular in shape, it is appreciated, however, that the cover substrate may be formed in a variety of shapes and sizes in accordance with this disclosure.
Cover substrate 20 is formed from a flexible polymer and preferably from a polymer such as polyester. A non-limiting example of a suitable polymer is 3.9 mil (99 um) thick 3M
hydrophilic polyester film (3M Product #9971), commercially available from 3M
Healthcare, St. Paul, MN.
Referring now to Figs. 1 and 3, the capillary channel 60 is generally linear in shape and is defined by the cover substrate 20, the electrode support substrate 12, and the border 54 of the spacer substrate 18. When biosensor 10 is assembled, channel 60 extends across the electrode array 36. Cover substrate 20 does not extend across the entire notch 52, therefore, a portion of the notch serves as an air outlet in accordance with this disclosure.
An electrochemical reagent 62 is positioned on the array 36. The reagent 62 provides electrochemical probes for specific analytes. The term analyte, as used herein, refers to the molecule or compound to be quantitatively determined. Non-limiting examples of analytes include carbohydrates, proteins, such as hormones and other secreted proteins, enzymes, and cell surface proteins; glycoproteins; peptides; small molecules;
polysaccharides; antibodies (including monoclonal or polyclonal Ab); nucleic acids; drugs; toxins; viruses of virus particles; portions of a cell wall; and other compounds processing epitopes.
The analyte of interest is preferably glucose.
The choice of the specific reagent 62 depends on the specific analyte or analytes to be measured, and are well known to those of ordinary skill in the art. An example of a reagent that may be used in biosensor 10 of the present invention is a reagent for measuring glucose from a whole blood sample. A non-limiting example of a reagent for measurement of glucose in a human blood sample contains 62.2 mg polyethylene oxide (mean molecular weight of 100-900 kilo Daltons), 3.3 mg NATROSOL* 244M, 41.5 mg AVICEL* RC-591 F, 89.4 mg monobasic potassium phosphate, 157.9 mg dibasic potassium phosphate, 437.3 mg potassium ferncyanide, 46.0 mg sodium succinate, 148.0 mg trehalose, 2.6 mg TRITON X-100*
surfactant, and 2,000 to 9,000 units of enzyme activity per gram of reagent.
The enzyme is prepared as an enzyme solution from 12.5 mg coenzyme PQQ and 1.21 million units of the apoenzyme of quinoprotein glucose dehydrogenase. This reagent is further described in U.S.
Patent No. 5,997,817.
Non-limiting examples of enzymes and mediators that may be used in measuring particular analytes in biosensor 10 are listed below in Table 1.
* trade-mark Analyte Enzymes Mediator Additional Mediator (Oxidized Form) Glucose Glucose Dehydrogenase Ferricyanide and Diavhorase ucose-Cholesterol Oxidase Benzoquinone 2,5-Dichloro-1,4-Benzoquinone or Phenazine Ethosulfate HDL Cholesterol EsteraseFerricyanide2,6-Dimethyl-1,4-Cholesteroland Cholesterol Benzoquinone Oxidase 2,5-Dichloro-1,4-Benzoquinone or Phenazine Ethosulfate TriglyceridesLipoprotein Lipase,Ferricyanideor Phenazine Methosulfate Glycerol Kinase, Phenazine and Glycerol-3-PhosphateEthosulfate Oxidase Lactate Lactate Oxidase Ferricyanide2,6-Dichloro-1,4-Lactate Lactate Dehydrogenase Ferricyanide and Diaphorase Phenazine Ethosulfate, or Phenazine Methosulfate Lactate Diaphorase Ferricyanide Phenazine Ethosulfate, or Dehvdro~enase Phenazine Methosulfate Bilirubin Bilirubin Oxidase 1-Methoxy-Phenazine Methosulfate Uric Acid Uricase Ferricyanide In some of the examples shown in Table 1, at least one additional enzyme is used as a reaction catalyst. Also, some of the examples shown in Table 1 may utilize an additional mediator, which facilitates electron transfer to the oxidized form of the mediator. The additional mediator may be provided to the reagent in lesser amount than the oxidized form of the mediator. While the above assays are described, it is contemplated that current, charge, impedance, conductance, potential, or other electrochemically indicated property of the sample might be accurately correlated to the concentration of the analyte in the sample with biosensor 10 in accordance with this disclosure.
A plurality of biosensors 10 are typically packaged in a vial, usually with a stopper formed to seal the vial. It is appreciated, however, that biosensors 10 may be packaged individually, or biosensors can be folded upon one another, rolled in a coil, stacked in a cassette magazine, or packed in blister packaging.
Biosensor 10 is used in conjunction with the following:
1. a power source in electrical connection with contacts 34 and capable of supplying an electrical potential difference between electrodes 14, 16 sufficient to cause diffusion limited electro-oxidation of the reduced form of the mediator at the surface of the working electrode;
and 2. a meter in electrical connection with contacts 34 and capable of measuring the diffusion limited current produced by oxidation of the reduced form of the mediator with the above-stated electrical potential difference is applied.
The meter is provided with a pattern reader that is capable of reading the code pattern 40 into a memory of the meter. The reader can be an electrical or optical reader in accordance with the present invention. The reader is formed to read the code pattern 40 when the biosensor 10 is inserted into the meter. When, however, the code pattern is in a human readable form, it is appreciated that the meter may include an interface, which permits the user to input the information from the code pattern manually. There are many ways to optically read code pattern 40 such as laser scanners, pen-like wands, and charge-couple-device (CCD) scanners.
A non-limiting example of a suitable optical reader suitable for use with the present invention includes a light emitting diodes) (LED), a lens, and a photodiode. It is appreciated that the reader may be an independent internal component of the meter.
The meter may further be formed to transfer the code pattern from the meter to a memory unit where it is stored. It is appreciated that the memory unit can be formed to store information regarding the specifics of the code pattern as well as patient information including previous meter readings. The meter will normally be adapted to apply an algorithm to the current measurement, whereby an analyte concentration is provided and visually displayed. Improvements in such power source, meter, and biosensor system are the subject of commonly assigned U.S. Pat. No. 4,963,814, issued Oct. 16, 1990; U.S. Pat. No.
4,999,632, issued Mar. 12, 1991; U.S. Pat. No. 4,999,582, issued Mar. 12, 1991; U.S. Pat.
No. 5,243,516, issued Sep. 7, 1993; U.S. Pat. No. 5,352,351, issued Oct. 4, 1994; U.S. Pat.
No. 5,366,609, issued Nov. 22, 1994; White et al., U.S. Pat. No. 5,405,51 l, issued Apr. 11, 1995; and White et al., U.S. Pat. No. 5,438,271, issued Aug. 1, 1995.
Many fluid samples may be analyzed. For example, human body fluids such as whole blood, plasma, sera, lymph, bile, urine, semen, cerebrospinal fluid, spinal fluid, lacrimal fluid and stool specimens as well as other biological fluids readily apparent to one skilled in the art may 5 be measured. Fluid preparations of tissues can also be assayed, along with foods, fermentation products and environmental substances, which potentially contain environmental contaminants. Preferably, whole blood is assayed with this invention.
To manufacture biosensor 10 a roll of metallized electrode support material is fed through guide rolls into an ablation/washing and drying station. A laser system capable of ablating 10 support 12 is known to those of ordinary skill in the art. Non-limiting examples of which include excimer lasers, with the pattern of ablation controlled by mirrors, lenses, and masks.
A non-limiting example of such a custom fit system is the LPX-300 or LPX-200 both commercially available from LPKF Laser Electronic GmbH, of Garbsen, Germany.
In the laser ablation station, the metallic layer of the metallized film is ablated at 70 in a pre-determined pattern, to form a ribbon of isolated electrode sets on the electrode support material, code patterns, and a recess in the film adjacent to each electrode array. To ablate electrodes 14, 16, recess 35, and code patterns 40 in 50 nm thick gold conductor 13, 90 mJ/cm2 energy is applied. It is appreciated, however, that the amount of energy required may vary from material to material, metal to metal, or thickness to thickness. The ribbon is then passed through more guide rolls, with a tension loop and through an optional inspection system where both optical and electrical inspection can be made. The system is used for quality control in order to check for defects.
Upon leaving the laser ablation station, the metallized film is fed into a reagent dispensing station. Reagents that have been compounded are fed into a dispensing station where it is applied in a liquid form to the center of respective the array 34. Reagent application techniques are well known to one of ordinary skill in the art as described in U.S. Patent No.
5,762,770. It is appreciated that reagents may be applied to the array 34 in a liquid or other form and dried or semi-dried onto the array 34 in accordance with this disclosure.
In a separate process, a double-sided pressure-sensitive film with dual release liners is fed into a window punch unit where notches are formed. The film is then fed into a lamination & kiss-cutting station. At the same time, a roll of cover substrate material is fed over a guide roll into the lamination & kiss-cutting station, where the release liner is removed from the upper surface 44 and rewound into a roll. The upper surface 33 of the spacer substrate material is applied to the cover substrate material. Next, the film is kiss cut and a portion of the cover substrate material is removed, leaving behind the cover substrate material coupled to the spacer substrate material, extending across a portion of the notch.
The cover material/spacer substrate subassembly is fed into a sensor lamination & cut/pack station. The reagent-coated electrode-support substrate material is fed from the dispensing station into the sensor lamination & cut/pack station as well. The remaining release liner is removed from the spacer substrate and the spacer substrate is positioned on the electrode-support substrate material so that at least a portion of the electrode array 36 is aligned with the notch 52. Next, the resulting assembled material is cut to form individual biosensors 10, which are sorted and packed into vials, each dosed with a stopper, to give packaged biosensor strips.
In use, the meter is turned on and the biosensor is inserted into the meter.
It is appreciated that the user may turn on the meter, or it may turn on automatically upon insertion of the biosensor. The LED emits a light that is directed through a lens towards the code pattern of the biosensor. The light is reflected off of the code pattern, through the lens, and toward the photodiode. The photodiode measures the intensity of the light that is reflected back from the code pattern and generates a corresponding voltage waveform. A decoder deciphers this waveform and translates it into a reading of the code pattern. It is appreciated that many commercially available optical readers may be used in accordance with the present invention.
Preferably, the optical reader will be custom fit reader.
In use, a user of biosensor 10 places a finger having a blood collection incision against the recess 35 in the notch 52. Capillary forces pull a liquid blood sample flowing from the incision through the capillary channel 60 across the reagent 62 and the array 34. The liquid blood sample dissolves the reagent 62 and engages the array 34 where the electrochemical reaction takes place.
In use for example, after the reaction is complete, a power source (e.g., a battery) applies a potential difference between the electrodes 14, 16 respectively. When the potential difference is applied, the amount of oxidized form of the mediator at the reference electrode and the potential difference must be sufficient to cause diffusion-limited electro-oxidation of the reduced form of the mediator at the surface of the working electrode. A
current measuring meter (not shown) measures the diffusion-limited current generated by the oxidation of the reduced form of the mediator at the surface of the working electrode.
The measured current may be accurately correlated to the concentration of the analyte in sample when the following requirements are satisfied:
1. The rate of oxidation of the reduced form of the mediator is governed by the rate of diffusion of the reduced form of the mediator to the surface of the working electrode.
The current produced is limited by the oxidation of reduced form of the mediator at the surface of the working electrode.
The processes and products described above include disposable biosensor 10 especially for use in diagnostic devices. Also included, however, are electrochemical sensors for non-diagnostic uses, such as measuring an analyte in any biological, environmental, or other sample. As discussed above, biosensor 10 can be manufactured in a variety of shapes and sizes and be used to perform a variety of assays, non-limiting examples of which include current, charge, impedance conductance, potential or other electrochemical indicative property of the sample applied to biosensor.
In accordance with another embodiment of the present invention, biosensor 110 is illustrated in Fig. 5. Biosensor 110 is formed in a similar manner to biosensor 10 except that biosensor 110 includes a code pattern 140. Code pattern 140 includes nine isolated pads 160. It is appreciated that the number of pads can be greater or fewer than nine in accordance with this disclosure. Each pad 160 is separated by from the surrounding electrical conductor by a gap 170.
Code pattern 140 is used once biosensor 110 is attached to a meter circuit board (not shown) that includes a connector. Generally, the connector will include two contacts per possible pad location on biosensor 110. Code pattern 140 of the present invention enables the meter to check continuity at each pad 160 location or determine that a pad does not exist in a pre-determined location. If a pad 160 is present, the meter will recognize the presence of a pad 160 by a continuity check. One of ordinary skill in the art will be well aware of methods suitable for performing a continuity check.
Code pattern 140 is formed from the electrical conductor by laser ablation using techniques as described above with reference to electrodes 14,16, shown for example in Fig.
1. Specifically, removing the electrical conductor in a pre-defined pattern to expose the first surface of the support substrate 12 creates the code pattern 140. Code pattern 140 can also be coated with a second electrical conductor (not shown) to modify the electrical resistivity of the pattern 140.
While pattern 140 illustratively includes nine spaced-apart generally square-shaped pads, it is appreciated that the pattern 140 can take on any number of shapes and patterns in accordance with this disclosure. In addition, it is appreciated that the pattern 140 can be read optically or electrically in accordance with this disclosure.
In use, when the user inserts biosensor 110 into the meter (not shown), the biosensor 110 makes contact to the connector and the electronics of the meter inquire as to how many pads 160 are showing continuity. Predetermined lot information may be stored in a memory unit of the meter. It is appreciated that the memory unit may also store a variety of patient information including previous meter readings. This memory unit is formed with memory components, a non-limiting example of which is known as RAM, which is well known in the prior art. The results of the continuity query may be used to set the appropriate code information in the meter, which enables the meter to eliminate chemistry or reagent variation.
In accordance with another embodiment of the present invention, biosensor 210 is illustrated in Fig. 6. Biosensor 210 is formed in a similar manner to biosensor 10, except that biosensor 210 includes a code pattern 240. Code pattern 240 includes nine pads 260 that are in communication with one another. It is appreciated that the number of pads can vary in accordance with this disclosure. Each pad 260 is separated from the surrounding electrical conductor by gaps 270.
Code pattern 240 is formed from the electrical conductor by laser ablation using techniques as described above with reference to electrodes 14, 16, shown for example in Fig.
1. Specifically, removing the electrical conductor in a pre-defined pattern to expose the first surface of the support substrate 12 creates the code pattern 240. Code pattern 240 can also be coated with a second electrical conductor (not shown) to modify the electrical resistivity of the pattern 240.
While pattern 240 illustratively includes nine generally square-shaped pads that are interconnected, it is appreciated that the pattern 240 can take an any number of shapes and patterns in accordance with this disclosure, which would give various resistance levels. These differing resistance levels can be correlated to a reagent lot. For example, the pattern 240 can be varied by disconnecting the internal links between the pads 260. This disconnection can be done, for example, by a laser. By changing the number of interconnected pads, the resistance of the remaining interconnected pads 260 will be different. In addition, it is appreciated that the pattern 240 can be read optically or electrically in accordance with this disclosure.
In use, when the user inserts biosensor 210 into the meter (not shown), the biosensor 210 makes contact to the connector and the electronics of the meter inquire as to how many pads 260 are showing continuity. Information related to this continuity is similar to that previously described with reference to biosensor 110.
In addition, the biosensor 210 will make contact with electronics of the meter, which determines the resistance between the interconnected pads. Thus, in preferred embodiments, the meter will determine which pads exist on the biosensor 210, and the resistance of the interconnected pads 260. The information can be stored in the meter as described above with reference to biosensors 10 and 110.
Although the invention has been described in detail with reference to a preferred embodiment, variations and modifications exist within the scope and spirit of the invention, on as described and defined in the following claims.
FIELD OF THE INVENTION
The present invention relates to a biosensor, more particularly to an electrochemical biosensor with a code pattern thereon.
BACKGROUND AND SUMMARY OF THE INVENTION
Electrochemical biosensors are known. They have been used to determine the concentration of various analytes from biological samples, particularly from blood.
Electrochemical biosensors are described in U.S. Patent Nos. 5,413,690; 5,762,770; 5,798,031;
and 5,997,817.
It is also known to include a code on a test strip that identifies the manufacturing batch of the strip. See WO 99122236.
According to one aspect of the present invention a biosensor is provided. The biosensor comprises a support substrate, an electrically conductive coating positioned on the support substrate, the coating being formed to define electrodes and a code pattern, wherein there is sufficient contrast between the conductive coating and the substrate such that the code pattern is discernible, and at least one reagent positioned on at least one electrode.
According to another aspect of the present invention a biosensor is provided.
The biosensor comprises a support substrate, an electrically conductive coating positioned on the support substrate, the coating being formed to define electrodes and a code pattern, wherein there is sufficient contrast between the conductive coating and the substrate such that the code pattern is discernible, and a cover cooperating with the support substrate to define a channel. At least a portion of the electrodes are positioned in the channel.
In addition, a method of forming a biosensor is provided in accordance with the present invention. The method comprises the steps of providing a substrate coated with an electrically conductive material, ablating the electrically conductive material to form electrodes and a code pattern, wherein there is sufficient contrast between the conductive coating and the substrate such that the code pattern is discernible, and applying a reagent to at least one of the electrodes.
Still further, in accordance with the present invention a biosensor is provided. The biosensor comprises a support substrate and an electrically conductive coating positioned on the support substrate. The coating is formed to define electrodes and means for identifying the biosensor, wherein there is sufficient contrast between the conductive coating and the substrate such that the identifying means is discernible.
Additional features of the invention will become apparent to those skilled in the art upon consideration of the following detailed description of the preferred embodiment exemplifying the best mode of carrying out the invention as presently perceived.
BRIEF DESCRIPTION OF THE DRAWINGS
The detailed description particularly refers to the accompanying figures in which:
Fig. 1 is a perspective view of a biosensor in accordance with the present invention, showing the biosensor formed to include a code pattern formed thereon.
Fig. 2 is an exploded assembly view of the biosensor of Fig. 1, showing the biosensor including an electrode array positioned at one end, a spacer substrate including a notch, and a cover formed to extend over a portion of the notch.
Fig. 3 is a view taken along lines 3-3 of Fig. 1.
Fig. 4 is a view taken along lines 4-4 of Fig. 1.
Fig. 5 is an enlarged top view of an alternative code pattern formed on a biosensor in accordance with the present invention.
Fig. 6 is an enlarged tap view of an alternative code pattern formed on a biosensor in accordance with the present invention.
DETAILED DESCRIPTION OF THE INVENTION
The present invention relates to a biosensor and a method for manufacturing a biosensor that has a specific code pattern. This code pattern is beneficially formed from the same electrically conductive material and in the same manner as the electrodes of the biosensor, which reduces steps in the manufacturing process. Laser ablation is preferably used in forming the code pattern while generating the electrode pattern. The code pattern can be read in a number of ways, non-limiting examples of which include optically or electrically depending on the structures formed onto the biosensor. The structures could show contrast in their optical reflectivity, their electrical conductivity, or their resistance respectively.
The structures could also be high reflectivity areas surrounded by low reflectivity areas or vice versa, or areas of high electrical conductivity surrounded by areas of low conductivity. Aspects of the invention are presented in Figs. 1-6, which are not drawn to scale and wherein like components in the several views are numbered alike.
Figs. 1-4 illustrate an aspect of the invention in the form of a biosensor 10 having an electrode-support substrate 12, an electrical conductor 13 positioned on the substrate 12 that is disrupted to define electrodes 14, 16, a spacer substrate 18 positioned on substrate 12, and a cover substrate 20 positioned on the spacer substrate 18. Biosensor 10 is preferably rectangular in shape. It is appreciated however, that biosensor 10 can assume any number of shapes in accordance with this disclosure. Biosensor 10 is preferably produced from rolls of material however, it is understood that biosensor 10 can be constructed from individual sheets in accordance with this disclosure. Thus, the selection of materials for the construction of biosensor 10 necessitates the use of materials that are sufficiently flexible for roll processing, but which are still rigid enough to give a useful stiffness to finished biosensor 10.
Referring to Fig. 4, the support substrate 12 includes a first surface 22 facing the spacer substrate 18 and a second surface 24. In addition, as shown in Fig. 2, substrate 12 has opposite first and second ends 26, 28 and opposite edges 30, 32 extending between the first and second ends 26, 28. Substrate 12 is generally rectangular in shape, it is appreciated however, that support may be formed in a variety of shapes and sizes in accordance with this disclosure.
Substrate 12 is formed of a flexible polymer and preferably from a flexible polymer and preferably from a polymer such as a polyester or polyimide, polyethylene naphthalate (PEN).
A non-limiting example of a suitable PEN is 5 mil ( 125 um) thick KALADEX~, a PEN film commercially available from E.I. DuPont de Nemours, Wilmington, Delaware, which is coated with gold by ROWO Coating, Henbolzhelm, Germany.
Electrodes 14, 16 are created or isolated from conductor 13 on first surface 22 of substrate 12.
Non-limiting examples of a suitable electrical conductor 13 include aluminum, carbon (such as graphite), cobalt, copper, gallium, gold, indium, iridium, iron, lead, magnesium, mercury (as an amalgam), nickel, niobium, osmium, palladium, platinum, rhenium, rhodium, selenium, silicon (such as highly doped polycrystalline silicon), silver, tantalum, tin, titanium, tungsten, uranium, vanadium, zinc, zirconium, mixtures thereof, and alloys, oxides, or metallic compounds of these elements. Preferably, electrical conductor 13 is selected from the following materials: gold, platinum, palladium, iridium, or alloys of these metals, since such noble metals and their alloys are unreactive in biological systems. Most preferably, electrical conductor 13 is gold.
Electrodes 14, 16 are isolated from the rest of the electrical conductor 13 by laser ablation.
See Fig. 4. Techniques for forming electrodes on a surface using laser ablation are known.
See, for example, U.S. Patent No. 6,662,439, entitled "LASER DEFINED FEATURES
FOR
PATTERNED LAMINATES AND ELECTRODE". Preferably, electrodes 14, 16 are created by removing the electrical conductor 13 from an area extending around the electrodes to form a gap of exposed support substrate 12. Therefore, electrodes 14, 16 are isolated from the rest of the electrically-conductive material on substrate 12 by a gap having a width of about 25 ~m to about 500 p,m, preferably the gap has a width of about 100 p,m to about 200 ~,m.
Alternatively, it is appreciated that electrodes 14, 16 may be created by laser ablation alone on substrate 12. It is appreciated that while laser ablation is the preferred method for forming electrodes 14, 16 given its precision and sensitivity, other techniques such as lamination, screen-printing, or photolithography may be used in accordance with this disclosure.
As shown in Fig. 2, electrodes 14, 16 cooperate with one another to define an electrode array 36. In addition, electrodes 14, 16 each include a contact 34 and a lead 38 extending between the contact 34 and the array 36. It is appreciated that the leads 38 extending from the array can be formed to have many lengths and extend to a variety of locations on the electrode-support substrate 12. It is appreciated that the configuration of the electrode array, the number of electrodes, as well as the spacing between the electrodes may vary in accordance with this disclosure and that a greater than one array may be formed as will be appreciated by one of skill in the art.
Refernng again to Figs. 2 and 3, a recess 35 is formed from the electrical conductor 13 by laser ablation using techniques as described above. Recess is created by removing the electrical conductor 13 to expose the first surface 22 of the support substrate 12 adjacent to the first end 26. It is appreciated that a portion of the first surface 22 may also be removed to form the recess 35 in accordance with this disclosure.
In addition, as shown in Figs. 1, 2, and 4, the discernible code pattern 40 is formed from the electrical conductor 13 by laser ablation using techniques as described above with reference to electrodes 14, 16. Specifically, the code pattern 40 is created by removing the electrical con-ductor 13 in a pre-defined pattern to expose the first surface 22 of the support substrate 12.
While pattern 40 is illustratively a barcode type pattern, it is appreciated that the pattern 40 S
can take on any number of shapes and patterns, non-limiting examples of which are shown in Figs. 5 and 6.
It is also appreciated that the pattern 40 can be provided in a human readable, optical readable, or electrical readable form in accordance with this disclosure. The structures could show contrast in their optical reflectivity, their electrical conductivity, or their resistivity respectively. To aid in contrasting the electrical conductivity of the code pattern 40, the electrical conductor 13 of the pattern 40 may be coated with a second conductive material (not shown) that is different from the electrical conductor 13. Non-limiting examples of the second conductive material include carbon and silver. It is appreciated, however, that a wide variety of materials may be coated on the electrical conductor 13 to change the electrical property of the code pattern 40.
It is also appreciated; electrodes 14, 16 could be formed from layers of electrically conductive materials having different colors, reflectivity, conductance, etc. Thus, the code pattern can be formed by removing a portion of the electrical conductor layers, leaving behind areas of high reflectivity surrounded by low reflectivity areas or vice versa, areas of high electrical conductivity surrounded by areas of low conductivity or vise versa. It is also possible to laser etch a code pattern that has a known resistance and this area can be read electrochemically to identify or recognize the code pattern. Moreover, it is appreciated that the code pattern can be a combination of any of the above readable forms in accordance with the present invention.
As shown in Fig. 4, the code pattern 40 is isolated from the rest of the electrically conductive material 13 on substrate 12 by gaps 42. Gaps 42 can have a wide variety of widths in accordance with this disclosure depending upon the specific use of the code pattern 40. Non-limiting examples of widths of the gaps include from about 1 ltm to about 1000 Vim.
Alternatively, it is appreciated that the code pattern 40 may be created by laser ablation alone on substrate 12. It is appreciated that while laser ablation is the preferred method for forming the code pattern 40 given its precision and sensitivity, other techniques such as lamination, screen-printing, or photolithography may be used in accordance with this disclosure.
The manufacturer of biosensor 10 may maintain a central database containing a set of code patterns, each of which uniquely identifies an individual biosensor, or batch of biosensors.
There may also be associated with each code pattern a set of calibration data for the biosensor 10. It is appreciated that the code patterns may be associated with any number of identification or data sets in accordance with the present invention.
Spacer substrate 18 of biosensor 10 includes an upper surface 44 and a lower surface 46 facing the substrate 12. In addition, the spacer substrate 18 includes opposite first and second ends 48, 50. First end 48 includes a notch 52, which is defined by a border 54. The border illustratively includes three generally linear sides. It is appreciated that the notch can take on a variety of shapes and sizes in accordance with this disclosure. When biosensor 10 is assembled, the border 54 extends about at least a portion of the array 36 so that the array 36 is at least partially exposed in the notch 52.
Spacer substrate 18 is formed of a flexible polymer and preferably from a flexible polymer and preferably from a polymer such as an adhesive coated polyethylene terephthalate (PET) polyester. A non-limiting example of a suitable PET is 3 mil (75 um) thick white PET film both sides of which are coated with a pressure-sensitive adhesive (Product #
ARcare 8877) commercially available from Adhesives Research, Inc. Glen Rock, Pennsylvania.
It is appreciated that spacer substrate 18 may be constructed of a variety of materials and may be coupled to the substrate 12 and the cover substrate 20 using a wide variety of commercially available adhesives, or by welding (heat or ultrasonic) when large portions of the surface 22 of the electrode support substrate 12 are exposed and not covered by electrical conductor 13.
The cover substrate 20 is coupled to the upper surface 44 of the spacer substrate 18. See Fig. 3.
The cover substrate 20 includes opposite first and second ends 56, 58. The cover substrate 20 is coupled to the spacer substrate 18 such that the first end 56 is spaced-apart from the end 48 of the spacer substrate 18 and the second end 58 is spaced-apart from the end 50 of the spacer substrate 18. When biosensor 10 is assembled, cover substrate 20 cooperates with the spacer support 20 and the electrode-support 12 to define a capillary channel 60.
Cover substrate 20 is generally rectangular in shape, it is appreciated, however, that the cover substrate may be formed in a variety of shapes and sizes in accordance with this disclosure.
Cover substrate 20 is formed from a flexible polymer and preferably from a polymer such as polyester. A non-limiting example of a suitable polymer is 3.9 mil (99 um) thick 3M
hydrophilic polyester film (3M Product #9971), commercially available from 3M
Healthcare, St. Paul, MN.
Referring now to Figs. 1 and 3, the capillary channel 60 is generally linear in shape and is defined by the cover substrate 20, the electrode support substrate 12, and the border 54 of the spacer substrate 18. When biosensor 10 is assembled, channel 60 extends across the electrode array 36. Cover substrate 20 does not extend across the entire notch 52, therefore, a portion of the notch serves as an air outlet in accordance with this disclosure.
An electrochemical reagent 62 is positioned on the array 36. The reagent 62 provides electrochemical probes for specific analytes. The term analyte, as used herein, refers to the molecule or compound to be quantitatively determined. Non-limiting examples of analytes include carbohydrates, proteins, such as hormones and other secreted proteins, enzymes, and cell surface proteins; glycoproteins; peptides; small molecules;
polysaccharides; antibodies (including monoclonal or polyclonal Ab); nucleic acids; drugs; toxins; viruses of virus particles; portions of a cell wall; and other compounds processing epitopes.
The analyte of interest is preferably glucose.
The choice of the specific reagent 62 depends on the specific analyte or analytes to be measured, and are well known to those of ordinary skill in the art. An example of a reagent that may be used in biosensor 10 of the present invention is a reagent for measuring glucose from a whole blood sample. A non-limiting example of a reagent for measurement of glucose in a human blood sample contains 62.2 mg polyethylene oxide (mean molecular weight of 100-900 kilo Daltons), 3.3 mg NATROSOL* 244M, 41.5 mg AVICEL* RC-591 F, 89.4 mg monobasic potassium phosphate, 157.9 mg dibasic potassium phosphate, 437.3 mg potassium ferncyanide, 46.0 mg sodium succinate, 148.0 mg trehalose, 2.6 mg TRITON X-100*
surfactant, and 2,000 to 9,000 units of enzyme activity per gram of reagent.
The enzyme is prepared as an enzyme solution from 12.5 mg coenzyme PQQ and 1.21 million units of the apoenzyme of quinoprotein glucose dehydrogenase. This reagent is further described in U.S.
Patent No. 5,997,817.
Non-limiting examples of enzymes and mediators that may be used in measuring particular analytes in biosensor 10 are listed below in Table 1.
* trade-mark Analyte Enzymes Mediator Additional Mediator (Oxidized Form) Glucose Glucose Dehydrogenase Ferricyanide and Diavhorase ucose-Cholesterol Oxidase Benzoquinone 2,5-Dichloro-1,4-Benzoquinone or Phenazine Ethosulfate HDL Cholesterol EsteraseFerricyanide2,6-Dimethyl-1,4-Cholesteroland Cholesterol Benzoquinone Oxidase 2,5-Dichloro-1,4-Benzoquinone or Phenazine Ethosulfate TriglyceridesLipoprotein Lipase,Ferricyanideor Phenazine Methosulfate Glycerol Kinase, Phenazine and Glycerol-3-PhosphateEthosulfate Oxidase Lactate Lactate Oxidase Ferricyanide2,6-Dichloro-1,4-Lactate Lactate Dehydrogenase Ferricyanide and Diaphorase Phenazine Ethosulfate, or Phenazine Methosulfate Lactate Diaphorase Ferricyanide Phenazine Ethosulfate, or Dehvdro~enase Phenazine Methosulfate Bilirubin Bilirubin Oxidase 1-Methoxy-Phenazine Methosulfate Uric Acid Uricase Ferricyanide In some of the examples shown in Table 1, at least one additional enzyme is used as a reaction catalyst. Also, some of the examples shown in Table 1 may utilize an additional mediator, which facilitates electron transfer to the oxidized form of the mediator. The additional mediator may be provided to the reagent in lesser amount than the oxidized form of the mediator. While the above assays are described, it is contemplated that current, charge, impedance, conductance, potential, or other electrochemically indicated property of the sample might be accurately correlated to the concentration of the analyte in the sample with biosensor 10 in accordance with this disclosure.
A plurality of biosensors 10 are typically packaged in a vial, usually with a stopper formed to seal the vial. It is appreciated, however, that biosensors 10 may be packaged individually, or biosensors can be folded upon one another, rolled in a coil, stacked in a cassette magazine, or packed in blister packaging.
Biosensor 10 is used in conjunction with the following:
1. a power source in electrical connection with contacts 34 and capable of supplying an electrical potential difference between electrodes 14, 16 sufficient to cause diffusion limited electro-oxidation of the reduced form of the mediator at the surface of the working electrode;
and 2. a meter in electrical connection with contacts 34 and capable of measuring the diffusion limited current produced by oxidation of the reduced form of the mediator with the above-stated electrical potential difference is applied.
The meter is provided with a pattern reader that is capable of reading the code pattern 40 into a memory of the meter. The reader can be an electrical or optical reader in accordance with the present invention. The reader is formed to read the code pattern 40 when the biosensor 10 is inserted into the meter. When, however, the code pattern is in a human readable form, it is appreciated that the meter may include an interface, which permits the user to input the information from the code pattern manually. There are many ways to optically read code pattern 40 such as laser scanners, pen-like wands, and charge-couple-device (CCD) scanners.
A non-limiting example of a suitable optical reader suitable for use with the present invention includes a light emitting diodes) (LED), a lens, and a photodiode. It is appreciated that the reader may be an independent internal component of the meter.
The meter may further be formed to transfer the code pattern from the meter to a memory unit where it is stored. It is appreciated that the memory unit can be formed to store information regarding the specifics of the code pattern as well as patient information including previous meter readings. The meter will normally be adapted to apply an algorithm to the current measurement, whereby an analyte concentration is provided and visually displayed. Improvements in such power source, meter, and biosensor system are the subject of commonly assigned U.S. Pat. No. 4,963,814, issued Oct. 16, 1990; U.S. Pat. No.
4,999,632, issued Mar. 12, 1991; U.S. Pat. No. 4,999,582, issued Mar. 12, 1991; U.S. Pat.
No. 5,243,516, issued Sep. 7, 1993; U.S. Pat. No. 5,352,351, issued Oct. 4, 1994; U.S. Pat.
No. 5,366,609, issued Nov. 22, 1994; White et al., U.S. Pat. No. 5,405,51 l, issued Apr. 11, 1995; and White et al., U.S. Pat. No. 5,438,271, issued Aug. 1, 1995.
Many fluid samples may be analyzed. For example, human body fluids such as whole blood, plasma, sera, lymph, bile, urine, semen, cerebrospinal fluid, spinal fluid, lacrimal fluid and stool specimens as well as other biological fluids readily apparent to one skilled in the art may 5 be measured. Fluid preparations of tissues can also be assayed, along with foods, fermentation products and environmental substances, which potentially contain environmental contaminants. Preferably, whole blood is assayed with this invention.
To manufacture biosensor 10 a roll of metallized electrode support material is fed through guide rolls into an ablation/washing and drying station. A laser system capable of ablating 10 support 12 is known to those of ordinary skill in the art. Non-limiting examples of which include excimer lasers, with the pattern of ablation controlled by mirrors, lenses, and masks.
A non-limiting example of such a custom fit system is the LPX-300 or LPX-200 both commercially available from LPKF Laser Electronic GmbH, of Garbsen, Germany.
In the laser ablation station, the metallic layer of the metallized film is ablated at 70 in a pre-determined pattern, to form a ribbon of isolated electrode sets on the electrode support material, code patterns, and a recess in the film adjacent to each electrode array. To ablate electrodes 14, 16, recess 35, and code patterns 40 in 50 nm thick gold conductor 13, 90 mJ/cm2 energy is applied. It is appreciated, however, that the amount of energy required may vary from material to material, metal to metal, or thickness to thickness. The ribbon is then passed through more guide rolls, with a tension loop and through an optional inspection system where both optical and electrical inspection can be made. The system is used for quality control in order to check for defects.
Upon leaving the laser ablation station, the metallized film is fed into a reagent dispensing station. Reagents that have been compounded are fed into a dispensing station where it is applied in a liquid form to the center of respective the array 34. Reagent application techniques are well known to one of ordinary skill in the art as described in U.S. Patent No.
5,762,770. It is appreciated that reagents may be applied to the array 34 in a liquid or other form and dried or semi-dried onto the array 34 in accordance with this disclosure.
In a separate process, a double-sided pressure-sensitive film with dual release liners is fed into a window punch unit where notches are formed. The film is then fed into a lamination & kiss-cutting station. At the same time, a roll of cover substrate material is fed over a guide roll into the lamination & kiss-cutting station, where the release liner is removed from the upper surface 44 and rewound into a roll. The upper surface 33 of the spacer substrate material is applied to the cover substrate material. Next, the film is kiss cut and a portion of the cover substrate material is removed, leaving behind the cover substrate material coupled to the spacer substrate material, extending across a portion of the notch.
The cover material/spacer substrate subassembly is fed into a sensor lamination & cut/pack station. The reagent-coated electrode-support substrate material is fed from the dispensing station into the sensor lamination & cut/pack station as well. The remaining release liner is removed from the spacer substrate and the spacer substrate is positioned on the electrode-support substrate material so that at least a portion of the electrode array 36 is aligned with the notch 52. Next, the resulting assembled material is cut to form individual biosensors 10, which are sorted and packed into vials, each dosed with a stopper, to give packaged biosensor strips.
In use, the meter is turned on and the biosensor is inserted into the meter.
It is appreciated that the user may turn on the meter, or it may turn on automatically upon insertion of the biosensor. The LED emits a light that is directed through a lens towards the code pattern of the biosensor. The light is reflected off of the code pattern, through the lens, and toward the photodiode. The photodiode measures the intensity of the light that is reflected back from the code pattern and generates a corresponding voltage waveform. A decoder deciphers this waveform and translates it into a reading of the code pattern. It is appreciated that many commercially available optical readers may be used in accordance with the present invention.
Preferably, the optical reader will be custom fit reader.
In use, a user of biosensor 10 places a finger having a blood collection incision against the recess 35 in the notch 52. Capillary forces pull a liquid blood sample flowing from the incision through the capillary channel 60 across the reagent 62 and the array 34. The liquid blood sample dissolves the reagent 62 and engages the array 34 where the electrochemical reaction takes place.
In use for example, after the reaction is complete, a power source (e.g., a battery) applies a potential difference between the electrodes 14, 16 respectively. When the potential difference is applied, the amount of oxidized form of the mediator at the reference electrode and the potential difference must be sufficient to cause diffusion-limited electro-oxidation of the reduced form of the mediator at the surface of the working electrode. A
current measuring meter (not shown) measures the diffusion-limited current generated by the oxidation of the reduced form of the mediator at the surface of the working electrode.
The measured current may be accurately correlated to the concentration of the analyte in sample when the following requirements are satisfied:
1. The rate of oxidation of the reduced form of the mediator is governed by the rate of diffusion of the reduced form of the mediator to the surface of the working electrode.
The current produced is limited by the oxidation of reduced form of the mediator at the surface of the working electrode.
The processes and products described above include disposable biosensor 10 especially for use in diagnostic devices. Also included, however, are electrochemical sensors for non-diagnostic uses, such as measuring an analyte in any biological, environmental, or other sample. As discussed above, biosensor 10 can be manufactured in a variety of shapes and sizes and be used to perform a variety of assays, non-limiting examples of which include current, charge, impedance conductance, potential or other electrochemical indicative property of the sample applied to biosensor.
In accordance with another embodiment of the present invention, biosensor 110 is illustrated in Fig. 5. Biosensor 110 is formed in a similar manner to biosensor 10 except that biosensor 110 includes a code pattern 140. Code pattern 140 includes nine isolated pads 160. It is appreciated that the number of pads can be greater or fewer than nine in accordance with this disclosure. Each pad 160 is separated by from the surrounding electrical conductor by a gap 170.
Code pattern 140 is used once biosensor 110 is attached to a meter circuit board (not shown) that includes a connector. Generally, the connector will include two contacts per possible pad location on biosensor 110. Code pattern 140 of the present invention enables the meter to check continuity at each pad 160 location or determine that a pad does not exist in a pre-determined location. If a pad 160 is present, the meter will recognize the presence of a pad 160 by a continuity check. One of ordinary skill in the art will be well aware of methods suitable for performing a continuity check.
Code pattern 140 is formed from the electrical conductor by laser ablation using techniques as described above with reference to electrodes 14,16, shown for example in Fig.
1. Specifically, removing the electrical conductor in a pre-defined pattern to expose the first surface of the support substrate 12 creates the code pattern 140. Code pattern 140 can also be coated with a second electrical conductor (not shown) to modify the electrical resistivity of the pattern 140.
While pattern 140 illustratively includes nine spaced-apart generally square-shaped pads, it is appreciated that the pattern 140 can take on any number of shapes and patterns in accordance with this disclosure. In addition, it is appreciated that the pattern 140 can be read optically or electrically in accordance with this disclosure.
In use, when the user inserts biosensor 110 into the meter (not shown), the biosensor 110 makes contact to the connector and the electronics of the meter inquire as to how many pads 160 are showing continuity. Predetermined lot information may be stored in a memory unit of the meter. It is appreciated that the memory unit may also store a variety of patient information including previous meter readings. This memory unit is formed with memory components, a non-limiting example of which is known as RAM, which is well known in the prior art. The results of the continuity query may be used to set the appropriate code information in the meter, which enables the meter to eliminate chemistry or reagent variation.
In accordance with another embodiment of the present invention, biosensor 210 is illustrated in Fig. 6. Biosensor 210 is formed in a similar manner to biosensor 10, except that biosensor 210 includes a code pattern 240. Code pattern 240 includes nine pads 260 that are in communication with one another. It is appreciated that the number of pads can vary in accordance with this disclosure. Each pad 260 is separated from the surrounding electrical conductor by gaps 270.
Code pattern 240 is formed from the electrical conductor by laser ablation using techniques as described above with reference to electrodes 14, 16, shown for example in Fig.
1. Specifically, removing the electrical conductor in a pre-defined pattern to expose the first surface of the support substrate 12 creates the code pattern 240. Code pattern 240 can also be coated with a second electrical conductor (not shown) to modify the electrical resistivity of the pattern 240.
While pattern 240 illustratively includes nine generally square-shaped pads that are interconnected, it is appreciated that the pattern 240 can take an any number of shapes and patterns in accordance with this disclosure, which would give various resistance levels. These differing resistance levels can be correlated to a reagent lot. For example, the pattern 240 can be varied by disconnecting the internal links between the pads 260. This disconnection can be done, for example, by a laser. By changing the number of interconnected pads, the resistance of the remaining interconnected pads 260 will be different. In addition, it is appreciated that the pattern 240 can be read optically or electrically in accordance with this disclosure.
In use, when the user inserts biosensor 210 into the meter (not shown), the biosensor 210 makes contact to the connector and the electronics of the meter inquire as to how many pads 260 are showing continuity. Information related to this continuity is similar to that previously described with reference to biosensor 110.
In addition, the biosensor 210 will make contact with electronics of the meter, which determines the resistance between the interconnected pads. Thus, in preferred embodiments, the meter will determine which pads exist on the biosensor 210, and the resistance of the interconnected pads 260. The information can be stored in the meter as described above with reference to biosensors 10 and 110.
Although the invention has been described in detail with reference to a preferred embodiment, variations and modifications exist within the scope and spirit of the invention, on as described and defined in the following claims.
Claims (19)
1. A biosensor comprising:
a support substrate, an electrically conductive coating positioned on the support substrate, the coating being formed to define electrodes and at least one reagent positioned on at least one electrode, said coating being formed to define a code pattern for identifying the biosensor, the code pattern being isolated from the rest of the electrically conductive material and wherein there is sufficient contrast between the conductive coating and the substrate such that the identifying means is optically discernible.
a support substrate, an electrically conductive coating positioned on the support substrate, the coating being formed to define electrodes and at least one reagent positioned on at least one electrode, said coating being formed to define a code pattern for identifying the biosensor, the code pattern being isolated from the rest of the electrically conductive material and wherein there is sufficient contrast between the conductive coating and the substrate such that the identifying means is optically discernible.
2. The biosensor of claim 1, further comprising a cover that cooperates with the support substrate to define a channel and at least a portion of the electrodes are positioned in the channel.
3. The biosensor of claim 1, wherein the code pattern is a bar code.
4. The biosensor of any one of claims 1 - 3, wherein the conductive coating is gold.
5. The biosensor of any one of claims 1 - 5, further comprising a second electrically conductive coating positioned on the code pattern.
6. The biosensor of claim 1, wherein the code pattern additionally is electrically discernible.
7. The biosensor of claim 1, wherein the code pattern includes recesses formed in the conductive coating.
8. The biosensor of claim 1, wherein the support substrate includes opposite first and second ends and the code pattern is positioned adjacent to the second end.
9. The biosensor of claim 1, further comprising a cover substrate extending across at least a portion of the electrodes.
10. The biosensor of claim 1, wherein the code pattern includes pads that are spaced-apart from the surrounding electrically conductive coating.
11. The biosensor of claim 10, wherein the pads are isolated from one another.
12. The biosensor of claim 10, wherein the pads are interconnected.
13. The biosensor of any one of claims 1 to 12, wherein the electrodes cooperate to define an array positioned adjacent to the first end.
14. The biosensor of claim 13, wherein the channel extends from the first end to the array.
15. A method of forming a biosensor, the method comprising the steps of:
providing a substrate coated with a electrically conductive material, ablating the electrically conductive material to form electrodes and a code pattern, wherein there is sufficient contrast between the conductive coating and the substrate such that the code pattern is discernible, and applying a reagent to at least one of the electrodes.
providing a substrate coated with a electrically conductive material, ablating the electrically conductive material to form electrodes and a code pattern, wherein there is sufficient contrast between the conductive coating and the substrate such that the code pattern is discernible, and applying a reagent to at least one of the electrodes.
16. The method of claim 15, wherein the ablating step includes the step of laser ablating the electrically conductive material.
17. The method of claim 16, wherein the ablating step includes forming a bar code shaped code pattern.
18. The method of claim 15, wherein the ablating step includes forming the code pattern that includes pads isolated from the surrounding electrically conductive material.
19. The method of claim 18, wherein the pads are interconnected.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002547681A CA2547681C (en) | 2001-08-29 | 2002-08-27 | Biosensor |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/942,515 | 2001-08-29 | ||
US09/942,515 US6814844B2 (en) | 2001-08-29 | 2001-08-29 | Biosensor with code pattern |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002547681A Division CA2547681C (en) | 2001-08-29 | 2002-08-27 | Biosensor |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2399887A1 CA2399887A1 (en) | 2003-02-28 |
CA2399887C true CA2399887C (en) | 2006-08-08 |
Family
ID=25478187
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002399887A Expired - Lifetime CA2399887C (en) | 2001-08-29 | 2002-08-27 | Biosensor |
Country Status (6)
Country | Link |
---|---|
US (3) | US6814844B2 (en) |
EP (1) | EP1288653B2 (en) |
JP (2) | JP4098031B2 (en) |
AT (1) | ATE511640T1 (en) |
CA (1) | CA2399887C (en) |
ES (1) | ES2367102T5 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8417545B2 (en) | 2007-02-15 | 2013-04-09 | Abbott Diabetes Care Inc. | Device and method for automatic data acquisition and/or detection |
US10022499B2 (en) | 2007-02-15 | 2018-07-17 | Abbott Diabetes Care Inc. | Device and method for automatic data acquisition and/or detection |
Families Citing this family (233)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6036924A (en) | 1997-12-04 | 2000-03-14 | Hewlett-Packard Company | Cassette of lancet cartridges for sampling blood |
US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US8419650B2 (en) | 1999-04-16 | 2013-04-16 | Cariocom, LLC | Downloadable datasets for a patient monitoring system |
US6290646B1 (en) | 1999-04-16 | 2001-09-18 | Cardiocom | Apparatus and method for monitoring and communicating wellness parameters of ambulatory patients |
US6841052B2 (en) | 1999-08-02 | 2005-01-11 | Bayer Corporation | Electrochemical-sensor design |
US20050103624A1 (en) | 1999-10-04 | 2005-05-19 | Bhullar Raghbir S. | Biosensor and method of making |
US7073246B2 (en) * | 1999-10-04 | 2006-07-11 | Roche Diagnostics Operations, Inc. | Method of making a biosensor |
US6616819B1 (en) | 1999-11-04 | 2003-09-09 | Therasense, Inc. | Small volume in vitro analyte sensor and methods |
US20060091006A1 (en) * | 1999-11-04 | 2006-05-04 | Yi Wang | Analyte sensor with insertion monitor, and methods |
US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7682318B2 (en) | 2001-06-12 | 2010-03-23 | Pelikan Technologies, Inc. | Blood sampling apparatus and method |
US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7025774B2 (en) | 2001-06-12 | 2006-04-11 | Pelikan Technologies, Inc. | Tissue penetration device |
EP1404235A4 (en) | 2001-06-12 | 2008-08-20 | Pelikan Technologies Inc | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
JP4149911B2 (en) | 2001-06-12 | 2008-09-17 | ペリカン テクノロジーズ インコーポレイテッド | Electric lancet actuator |
EP1404233B1 (en) | 2001-06-12 | 2009-12-02 | Pelikan Technologies Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
ATE497731T1 (en) | 2001-06-12 | 2011-02-15 | Pelikan Technologies Inc | DEVICE FOR INCREASING THE SUCCESS RATE OF BLOOD YIELD OBTAINED BY A FINGER PICK |
US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US6814844B2 (en) | 2001-08-29 | 2004-11-09 | Roche Diagnostics Corporation | Biosensor with code pattern |
US8360992B2 (en) | 2002-04-19 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7226461B2 (en) | 2002-04-19 | 2007-06-05 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US7648468B2 (en) | 2002-04-19 | 2010-01-19 | Pelikon Technologies, Inc. | Method and apparatus for penetrating tissue |
US8372016B2 (en) | 2002-04-19 | 2013-02-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling and analyte sensing |
US7717863B2 (en) | 2002-04-19 | 2010-05-18 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7371247B2 (en) | 2002-04-19 | 2008-05-13 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7175642B2 (en) | 2002-04-19 | 2007-02-13 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
US7291117B2 (en) | 2002-04-19 | 2007-11-06 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US6743635B2 (en) * | 2002-04-25 | 2004-06-01 | Home Diagnostics, Inc. | System and methods for blood glucose sensing |
US7470533B2 (en) | 2002-12-20 | 2008-12-30 | Acea Biosciences | Impedance based devices and methods for use in assays |
US7560269B2 (en) | 2002-12-20 | 2009-07-14 | Acea Biosciences, Inc. | Real time electronic cell sensing system and applications for cytotoxicity profiling and compound assays |
US8263375B2 (en) | 2002-12-20 | 2012-09-11 | Acea Biosciences | Dynamic monitoring of activation of G-protein coupled receptor (GPCR) and receptor tyrosine kinase (RTK) in living cells using real-time microelectronic cell sensing technology |
US11346797B2 (en) | 2002-12-20 | 2022-05-31 | Agilent Technologies, Inc. | System and method for monitoring cardiomyocyte beating, viability, morphology and electrophysiological properties |
US10215748B2 (en) | 2002-12-20 | 2019-02-26 | Acea Biosciences, Inc. | Using impedance-based cell response profiling to identify putative inhibitors for oncogene addicted targets or pathways |
US10551371B2 (en) | 2003-11-10 | 2020-02-04 | Acea Biosciences, Inc. | System and method for monitoring cardiomyocyte beating, viability and morphology and for screening for pharmacological agents which may induce cardiotoxicity or modulate cardiomyocyte function |
US10539523B2 (en) | 2002-12-20 | 2020-01-21 | Acea Biosciences, Inc. | System and method for monitoring cardiomyocyte beating, viability, morphology, and electrophysiological properties |
US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
ES2347248T3 (en) | 2003-05-30 | 2010-10-27 | Pelikan Technologies Inc. | PROCEDURE AND APPLIANCE FOR FLUID INJECTION. |
WO2005001444A1 (en) * | 2003-06-03 | 2005-01-06 | Bayer Healthcare Llc. | Verification device and method for optical inspection machine |
US7850621B2 (en) | 2003-06-06 | 2010-12-14 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
US7544277B2 (en) * | 2003-06-12 | 2009-06-09 | Bayer Healthcare, Llc | Electrochemical test sensors |
US8148164B2 (en) | 2003-06-20 | 2012-04-03 | Roche Diagnostics Operations, Inc. | System and method for determining the concentration of an analyte in a sample fluid |
US7645373B2 (en) | 2003-06-20 | 2010-01-12 | Roche Diagnostic Operations, Inc. | System and method for coding information on a biosensor test strip |
CA2529378C (en) | 2003-06-20 | 2014-04-15 | F.Hoffmann-La Roche Ag | Method and reagent for producing narrow, homogenous reagent strips |
US8058077B2 (en) | 2003-06-20 | 2011-11-15 | Roche Diagnostics Operations, Inc. | Method for coding information on a biosensor test strip |
WO2004113909A1 (en) * | 2003-06-20 | 2004-12-29 | Roche Diagnostics Gmbh | System and method for coding information on a biosensor test strip |
US7718439B2 (en) * | 2003-06-20 | 2010-05-18 | Roche Diagnostics Operations, Inc. | System and method for coding information on a biosensor test strip |
US8679853B2 (en) | 2003-06-20 | 2014-03-25 | Roche Diagnostics Operations, Inc. | Biosensor with laser-sealed capillary space and method of making |
ES2657627T3 (en) * | 2003-06-20 | 2018-03-06 | F. Hoffmann-La Roche Ag | Electrochemical biosensors |
US7604721B2 (en) * | 2003-06-20 | 2009-10-20 | Roche Diagnostics Operations, Inc. | System and method for coding information on a biosensor test strip |
US7645421B2 (en) | 2003-06-20 | 2010-01-12 | Roche Diagnostics Operations, Inc. | System and method for coding information on a biosensor test strip |
US8206565B2 (en) * | 2003-06-20 | 2012-06-26 | Roche Diagnostics Operation, Inc. | System and method for coding information on a biosensor test strip |
US8071030B2 (en) | 2003-06-20 | 2011-12-06 | Roche Diagnostics Operations, Inc. | Test strip with flared sample receiving chamber |
US7452457B2 (en) | 2003-06-20 | 2008-11-18 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement using dose sufficiency electrodes |
JP2007504438A (en) * | 2003-09-01 | 2007-03-01 | インバーネス・メデイカル・スウイツツアーランド・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング | Sampling device using capillary action |
EP1671096A4 (en) | 2003-09-29 | 2009-09-16 | Pelikan Technologies Inc | Method and apparatus for an improved sample capture device |
WO2005037095A1 (en) | 2003-10-14 | 2005-04-28 | Pelikan Technologies, Inc. | Method and apparatus for a variable user interface |
CA2550274A1 (en) | 2003-11-12 | 2005-05-26 | Acea Biosciences, Inc. | Real time electronic cell sensing systems and applications for cell-based assays |
ATE476909T1 (en) * | 2003-11-13 | 2010-08-15 | Medtronic Minimed Inc | LONG-TERM ANALYT SENSOR ARRANGEMENT |
US8147426B2 (en) * | 2003-12-31 | 2012-04-03 | Nipro Diagnostics, Inc. | Integrated diagnostic test system |
US8394328B2 (en) * | 2003-12-31 | 2013-03-12 | Nipro Diagnostics, Inc. | Test strip container with integrated meter having strip coding capability |
US8668656B2 (en) | 2003-12-31 | 2014-03-11 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
US9012232B2 (en) * | 2005-07-15 | 2015-04-21 | Nipro Diagnostics, Inc. | Diagnostic strip coding system and related methods of use |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
US8394337B2 (en) * | 2003-12-31 | 2013-03-12 | Nipro Diagnostics, Inc. | Test strip container with integrated meter |
US7776559B2 (en) * | 2004-01-22 | 2010-08-17 | Hewlett-Packard Development Company, L.P. | Disposable blood test device |
CA2554060C (en) * | 2004-02-06 | 2013-04-16 | Bayer Healthcare Llc | Electrochemical biosensor |
EP1751546A2 (en) | 2004-05-20 | 2007-02-14 | Albatros Technologies GmbH & Co. KG | Printable hydrogel for biosensors |
WO2005120365A1 (en) | 2004-06-03 | 2005-12-22 | Pelikan Technologies, Inc. | Method and apparatus for a fluid sampling device |
US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
EP1810185A4 (en) | 2004-06-04 | 2010-01-06 | Therasense Inc | Diabetes care host-client architecture and data management system |
US7582262B2 (en) * | 2004-06-18 | 2009-09-01 | Roche Diagnostics Operations, Inc. | Dispenser for flattened articles |
US20060182656A1 (en) * | 2004-06-18 | 2006-08-17 | Tom Funke | Dispenser for flattened articles |
US7601299B2 (en) | 2004-06-18 | 2009-10-13 | Roche Diagnostics Operations, Inc. | System and method for coding information on a biosensor test strip |
US7569126B2 (en) * | 2004-06-18 | 2009-08-04 | Roche Diagnostics Operations, Inc. | System and method for quality assurance of a biosensor test strip |
JP2006015068A (en) * | 2004-07-05 | 2006-01-19 | Nishitomo Co Ltd | Biological information measuring sensor and biological information measuring apparatus |
US7418285B2 (en) * | 2004-12-29 | 2008-08-26 | Abbott Laboratories | Analyte test sensor and method of manufacturing the same |
US9351669B2 (en) | 2009-09-30 | 2016-05-31 | Abbott Diabetes Care Inc. | Interconnect for on-body analyte monitoring device |
US8029441B2 (en) | 2006-02-28 | 2011-10-04 | Abbott Diabetes Care Inc. | Analyte sensor transmitter unit configuration for a data monitoring and management system |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
US7545272B2 (en) | 2005-02-08 | 2009-06-09 | Therasense, Inc. | RF tag on test strips, test strip vials and boxes |
EP1877779A2 (en) | 2005-04-19 | 2008-01-16 | Bayer Healthcare LLC | Auto-calibration label and methods of forming the same |
US7875240B2 (en) | 2005-04-19 | 2011-01-25 | Bayer Healthcare Llc | Auto-calibration label and method of forming the same |
WO2006127635A1 (en) * | 2005-05-24 | 2006-11-30 | Bayer Healthcare Llc | Sensor package with an interim auto-calibration circuit |
US8594943B2 (en) | 2005-05-27 | 2013-11-26 | Bionime Gmbh | Coding module, a bio sensing meter and a system for operating a bio sensing meter |
TWI265677B (en) * | 2005-06-01 | 2006-11-01 | Bionime Corp | Coding module, bio measuring meter and system for operating bio measuring meter |
DE602005023433D1 (en) * | 2005-07-07 | 2010-10-21 | Asulab Sa | System for the differential determination of the amount of a proteolytic enzyme in a body fluid |
US8999125B2 (en) | 2005-07-15 | 2015-04-07 | Nipro Diagnostics, Inc. | Embedded strip lot autocalibration |
US7955856B2 (en) | 2005-07-15 | 2011-06-07 | Nipro Diagnostics, Inc. | Method of making a diagnostic test strip having a coding system |
EP1924848A2 (en) * | 2005-08-16 | 2008-05-28 | Home Diagnostics, Inc. | Method for test strip manufacturing and analysis |
GB0518527D0 (en) * | 2005-09-10 | 2005-10-19 | Oxford Biosensors Ltd | Scaling factor for an output of an electrochemical cell |
KR100680267B1 (en) | 2005-09-16 | 2007-02-08 | 주식회사 인포피아 | Biosensor had the identification information and reading apparatus for the identification information recorded a biosensor |
US7510985B1 (en) | 2005-10-26 | 2009-03-31 | Lpkf Laser & Electronics Ag | Method to manufacture high-precision RFID straps and RFID antennas using a laser |
US7955484B2 (en) * | 2005-12-14 | 2011-06-07 | Nova Biomedical Corporation | Glucose biosensor and method |
JP4670013B2 (en) * | 2006-02-03 | 2011-04-13 | 独立行政法人産業技術総合研究所 | Biosensor and manufacturing method thereof |
US8789756B2 (en) | 2006-02-25 | 2014-07-29 | Roche Diagnostics Operations, Inc. | Test element coding apparatuses, systems and methods |
US8388905B2 (en) * | 2006-03-13 | 2013-03-05 | Nipro Diagnostics, Inc. | Method and apparatus for coding diagnostic meters |
GB2436634A (en) * | 2006-03-28 | 2007-10-03 | Avantone Oy | Machine readable code system |
GB2436636A (en) * | 2006-03-28 | 2007-10-03 | Avantone Oy | Machine readable conductive array and devices for reading the same |
US8092385B2 (en) | 2006-05-23 | 2012-01-10 | Intellidx, Inc. | Fluid access interface |
EP1870046A1 (en) * | 2006-06-22 | 2007-12-26 | Roche Diagnostics GmbH | Bendable apparatus to introduce a medical apparatus in the body |
US20080020452A1 (en) * | 2006-07-18 | 2008-01-24 | Natasha Popovich | Diagnostic strip coding system with conductive layers |
US20080083618A1 (en) † | 2006-09-05 | 2008-04-10 | Neel Gary T | System and Methods for Determining an Analyte Concentration Incorporating a Hematocrit Correction |
US7740801B2 (en) * | 2006-10-31 | 2010-06-22 | Lifescan Scotland Limited | System for determination of an analyte in a bodily fluid sample that includes an electroluminescent component |
WO2008057479A2 (en) * | 2006-11-07 | 2008-05-15 | Bayer Healthcare Llc | Method of making an auto-calibrating test sensor |
US20090288964A1 (en) * | 2006-12-13 | 2009-11-26 | Sung-Kwon Jung | Biosensor with coded information and method for manufacturing the same |
KR100854389B1 (en) | 2007-02-28 | 2008-08-26 | 주식회사 아이센스 | Electrochemical biosensor |
AU2012201370B2 (en) * | 2007-03-02 | 2013-10-03 | I-Sens, Inc. | Electrochemical Biosensor Measuring System |
KR20080080841A (en) | 2007-03-02 | 2008-09-05 | 주식회사 아이센스 | Electrochemical biosensor |
KR100874158B1 (en) * | 2007-03-14 | 2008-12-15 | 주식회사 아이센스 | Electrochemical Biosensors and Measuring Instruments |
KR100874159B1 (en) * | 2007-03-28 | 2008-12-15 | 주식회사 아이센스 | Electrochemical Biosensors and Measuring Instruments |
US9029157B2 (en) | 2007-04-12 | 2015-05-12 | Nipro Diagnostics, Inc. | Error detection and rejection for a diagnostic testing system |
US20080274552A1 (en) * | 2007-05-04 | 2008-11-06 | Brian Guthrie | Dynamic Information Transfer |
US20080294024A1 (en) * | 2007-05-24 | 2008-11-27 | Cosentino Daniel L | Glucose meter system and monitor |
JP2009008574A (en) * | 2007-06-29 | 2009-01-15 | Sumitomo Electric Ind Ltd | Sensor chip, biosensor cartridge, and biosensor device |
US8206564B2 (en) * | 2007-07-23 | 2012-06-26 | Bayer Healthcare Llc | Biosensor calibration system |
CN101784894A (en) * | 2007-08-06 | 2010-07-21 | 拜尔健康护理有限责任公司 | The system and method for automatic calibration |
KR100896234B1 (en) * | 2007-08-10 | 2009-05-08 | 주식회사 아이센스 | Electrochemical biosensor and measuring instrument thereof |
KR20100083142A (en) * | 2007-10-10 | 2010-07-21 | 아가매트릭스, 인코포레이티드 | Identification method for electro chemical test strips |
TW200918896A (en) * | 2007-10-19 | 2009-05-01 | Hmd Biomedical Inc | Test stripe with identification function and testing device thereof |
JP2009115516A (en) * | 2007-11-02 | 2009-05-28 | National Institute Of Advanced Industrial & Technology | Biosensor |
US8241488B2 (en) | 2007-11-06 | 2012-08-14 | Bayer Healthcare Llc | Auto-calibrating test sensors |
US7809512B2 (en) * | 2007-11-11 | 2010-10-05 | Bayer Healthcare Llc | Biosensor coding system |
TW200925594A (en) * | 2007-12-07 | 2009-06-16 | Apex Biotechnology Corp | Biochemical test system, measurement device, biochemical test strip and method of making the same |
US20090145753A1 (en) | 2007-12-07 | 2009-06-11 | Apex Biotechnology Corp. | Biomechanical test system, measurement device, and biochemical test strip |
WO2009076263A1 (en) | 2007-12-10 | 2009-06-18 | Bayer Healthcare Llc | An auto-calibrating test sensor and method of making the same |
EP2254458A1 (en) * | 2008-02-04 | 2010-12-01 | Bayer HealthCare, LLC | Semiconductor based analyte sensors and methods |
US20090205399A1 (en) * | 2008-02-15 | 2009-08-20 | Bayer Healthcare, Llc | Auto-calibrating test sensors |
US20090223287A1 (en) * | 2008-03-04 | 2009-09-10 | Visgeneer, Inc. | Bio-Monitoring System and Methods of Use Thereof |
EP2098863A1 (en) | 2008-03-04 | 2009-09-09 | Visgeneer, Inc. | A bio-monitoring system and methods of use thereof |
JP5176612B2 (en) * | 2008-03-10 | 2013-04-03 | 住友電気工業株式会社 | Biosensor measuring instrument |
WO2009126900A1 (en) | 2008-04-11 | 2009-10-15 | Pelikan Technologies, Inc. | Method and apparatus for analyte detecting device |
JP5104527B2 (en) * | 2008-05-02 | 2012-12-19 | 住友電気工業株式会社 | Biosensor measuring instrument |
JP5104526B2 (en) * | 2008-05-02 | 2012-12-19 | 住友電気工業株式会社 | Biosensor measuring instrument and sensor system |
CA2723223C (en) | 2008-05-05 | 2017-06-06 | Acea Biosciences, Inc. | Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution |
JP5218826B2 (en) * | 2008-05-07 | 2013-06-26 | 住友電気工業株式会社 | Biosensor system, biosensor and biosensor measuring instrument |
US8124014B2 (en) | 2008-06-09 | 2012-02-28 | Bayer Healthcare Llc | Auto-calibration circuit or label and method of forming the same |
JP5405916B2 (en) * | 2008-06-24 | 2014-02-05 | パナソニック株式会社 | Biosensor, method for manufacturing the same, and detection system including the same |
US8032321B2 (en) * | 2008-07-15 | 2011-10-04 | Bayer Healthcare Llc | Multi-layered biosensor encoding systems |
US20100015006A1 (en) * | 2008-07-16 | 2010-01-21 | Tien-Tsai Hsu | Test strip with identification openings and test instrument using the same |
US8700114B2 (en) * | 2008-07-31 | 2014-04-15 | Medtronic Minmed, Inc. | Analyte sensor apparatuses comprising multiple implantable sensor elements and methods for making and using them |
US20100025238A1 (en) * | 2008-07-31 | 2010-02-04 | Medtronic Minimed, Inc. | Analyte sensor apparatuses having improved electrode configurations and methods for making and using them |
KR101013184B1 (en) | 2008-08-22 | 2011-02-10 | 주식회사 아이센스 | Biosensor measuring apparatus and a method thereof |
CA2735606A1 (en) * | 2008-09-19 | 2010-03-25 | Bayer Healthcare Llc | Lancet analyte sensors and methods of manufacturing |
CN102171557B (en) | 2008-09-19 | 2016-10-19 | 安晟信医疗科技控股公司 | There is electrochemical appliance and the manufacture method thereof of the electro-chemical activity of enhancing |
EP2341830A4 (en) * | 2008-09-19 | 2012-10-31 | Bayer Healthcare Llc | Analyte sensors, systems, testing apparatus and manufacturing methods |
US8551400B2 (en) * | 2008-09-19 | 2013-10-08 | Bayer Healthcare Llc | Analyte sensors, testing apparatus and manufacturing methods |
US8424763B2 (en) * | 2008-10-07 | 2013-04-23 | Bayer Healthcare Llc | Method of forming an auto-calibration circuit or label |
US8586911B2 (en) * | 2008-10-21 | 2013-11-19 | Bayer Healthcare Llc | Optical readhead and method of using the same |
US20100112612A1 (en) * | 2008-10-30 | 2010-05-06 | John William Dilleen | Method for determining an analyte using an analytical test strip with a minimal fill-error viewing window |
US8012428B2 (en) | 2008-10-30 | 2011-09-06 | Lifescan Scotland, Ltd. | Analytical test strip with minimal fill-error sample viewing window |
KR101278605B1 (en) | 2008-11-04 | 2013-06-25 | 파나소닉 주식회사 | Measurement device, insulin infusion device, measurement method, method for controlling insulin infusion device, and program |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
WO2010091793A2 (en) * | 2009-01-30 | 2010-08-19 | Pelikan Technologies Gmbh & Co. Kg | Analyte measurement device with on-strip coding background |
US8696917B2 (en) | 2009-02-09 | 2014-04-15 | Edwards Lifesciences Corporation | Analyte sensor and fabrication methods |
TWM359696U (en) * | 2009-02-13 | 2009-06-21 | Apex Biotechnology Corp | Biochemical test system, measurement device, and biochemical test strip |
KR100903972B1 (en) | 2009-02-19 | 2009-06-25 | 주식회사 올메디쿠스 | Calibration method for bio-sensor |
US20100294660A1 (en) * | 2009-03-13 | 2010-11-25 | Tyson Bioresearch, Inc. | Glucose Testing Device And Strips For Same |
EP2228658A1 (en) * | 2009-03-13 | 2010-09-15 | Roche Diagnostics GmbH | Method for producing an analytical consumable |
KR101098993B1 (en) * | 2009-03-16 | 2011-12-29 | 영동전자 주식회사 | Biosensor and device for disease diagnosis using electrode |
US8753290B2 (en) | 2009-03-27 | 2014-06-17 | Intellectual Inspiration, Llc | Fluid transfer system and method |
US8608937B2 (en) | 2009-03-30 | 2013-12-17 | Roche Diagnostics Operations, Inc. | Biosensor with predetermined dose response curve and method of manufacturing |
KR101149818B1 (en) * | 2009-05-29 | 2012-05-25 | 주식회사 아이센스 | Electrochemical biosensor and measuring instrument thereof |
US8173008B2 (en) | 2009-06-24 | 2012-05-08 | Lifescan, Inc. | Method for determining an analyte in a bodily fluid sample using an analyte test strip with combination electrode contact and meter identification feature |
US20100326824A1 (en) * | 2009-06-24 | 2010-12-30 | Lifescan, Inc. | Analyte test strip with combination electrode contact and meter identification feature |
TWM375871U (en) * | 2009-08-21 | 2010-03-11 | Apex Biotechnology Corp | Biochemical test strip, measurement device, and biochemical test system |
KR101033649B1 (en) | 2009-09-04 | 2011-05-12 | 주식회사 필로시스 | Bio Sensor for Automatic Code Sensing and Code Sensing Method Using It |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
WO2011146531A1 (en) | 2010-05-18 | 2011-11-24 | Acea Biosciences, Inc | Data analysis of impedance-based cardiomyocyte-beating signals as detected on real-time cell analysis (rtca) cardio instruments |
US8940141B2 (en) | 2010-05-19 | 2015-01-27 | Lifescan Scotland Limited | Analytical test strip with an electrode having electrochemically active and inert areas of a predetermined size and distribution |
KR101703997B1 (en) * | 2010-06-08 | 2017-02-08 | 엘지전자 주식회사 | Test strip and assay device |
JP5698085B2 (en) * | 2010-07-12 | 2015-04-08 | アークレイ株式会社 | Biosensor and manufacturing method thereof |
US9176091B2 (en) * | 2010-09-17 | 2015-11-03 | Agamatrix, Inc. | Method and apparatus for encoding test strips |
JP2012104512A (en) * | 2010-11-05 | 2012-05-31 | Sharp Corp | Thin film solar cell module and method of manufacturing the same |
WO2012075644A1 (en) * | 2010-12-10 | 2012-06-14 | 红电医学科技股份有限公司 | Method for manufacturing fluid-detecting test piece |
US10136845B2 (en) | 2011-02-28 | 2018-11-27 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
TWI468687B (en) * | 2011-08-29 | 2015-01-11 | Bionime Corp | Test information can be bi-directional reconciliation of the biological measurement system and test the structure of the test piece |
CN103076441B (en) * | 2011-10-25 | 2015-08-19 | 华广生技股份有限公司 | The biological sensing measuring system that test piece information can two-wayly be checked |
KR101299795B1 (en) * | 2011-11-18 | 2013-08-23 | 주식회사 세라젬메디시스 | Biosensor having identification information and decipherment apparatus thereof |
CN104081210B (en) | 2011-12-23 | 2018-11-30 | 雅培医护站股份有限公司 | Optical detecting device with the actuating of pneumatic type sample |
EP2795328B1 (en) | 2011-12-23 | 2019-05-01 | Abbott Point of Care Inc. | Integrated test device for optical and electrochemical assays |
US9194859B2 (en) | 2011-12-23 | 2015-11-24 | Abbott Point Of Care Inc. | Reader devices for optical and electrochemical test devices |
WO2013096817A2 (en) | 2011-12-23 | 2013-06-27 | Abbott Point Of Care Inc | Integrated test device for optical detection of microarrays |
TWI504890B (en) * | 2012-01-06 | 2015-10-21 | Delbio Inc | Biosensors and bio-measurement systems |
KR101355883B1 (en) * | 2012-02-08 | 2014-01-28 | (주)정원기술 | Laser position correction device for making biosensor having width of tiny line and same method |
US8894831B2 (en) * | 2012-06-27 | 2014-11-25 | Roche Diagnostics Operations, Inc. | Printed memory on strip |
US9395234B2 (en) | 2012-12-05 | 2016-07-19 | Cardiocom, Llc | Stabilizing base for scale |
CN103123357A (en) * | 2013-01-08 | 2013-05-29 | 镇江博联电子科技有限公司 | Multi-type blood glucose test paper recognizing system and method and glucometer |
EP2770064A1 (en) * | 2013-02-22 | 2014-08-27 | F. Hoffmann-La Roche AG | Highly efficient production of blood glucose test strips |
US10168313B2 (en) * | 2013-03-15 | 2019-01-01 | Agamatrix, Inc. | Analyte detection meter and associated method of use |
JP6352954B2 (en) | 2013-03-15 | 2018-07-04 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Method and device for using information from recovery pulses in electrochemical analyte measurement, apparatus and system incorporating them |
JP6356707B2 (en) | 2013-03-15 | 2018-07-11 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Method for detecting high antioxidant levels during electrochemical measurements and then fail-safe analyte concentration and devices, apparatus and systems incorporating the same |
WO2014140172A1 (en) | 2013-03-15 | 2014-09-18 | Roche Diagnostics Gmbh | Methods of failsafing electrochemical measurements of an analyte as well as devices, apparatuses and systems incorporating the same |
EP3388823A1 (en) | 2013-03-15 | 2018-10-17 | Roche Diabetes Care GmbH | Methods of scaling data used to construct biosensor algorithms as well as devices, apparatuses and systems incorporating the same |
EP2984469B1 (en) * | 2013-04-09 | 2017-03-29 | Roche Diabetes Care GmbH | Protective covering for a hand-held medical device |
KR101526495B1 (en) * | 2013-04-29 | 2015-06-05 | 주식회사 인포피아 | Apparatus for recognizing identification information on a biosensor |
EP3049810A4 (en) * | 2013-09-24 | 2017-04-26 | Apollodx LLC | Systems and methods for diagnostic testing |
TWI498061B (en) * | 2013-12-20 | 2015-08-21 | Luxshare Ict Co Ltd | And a method of manufacturing a conductor line on an insulating substrate |
KR20160138100A (en) | 2014-03-07 | 2016-12-02 | 어센시아 다이어비티즈 케어 홀딩스 아게 | Biosensor calibration coding systems and methods |
US10024817B2 (en) | 2014-10-17 | 2018-07-17 | Pelogenix, Llc | Method for detecting proteases and active infection in biological fluids and tissues |
US10378098B2 (en) | 2015-03-18 | 2019-08-13 | Materion Corporation | Methods for optimized production of multilayer metal/transparent conducting oxide (TCO) constructs |
US10197522B2 (en) | 2015-03-18 | 2019-02-05 | Materion Corporation | Multilayer constructs for metabolite strips providing inert surface and mechanical advantage |
DK178966B1 (en) * | 2015-09-13 | 2017-07-10 | Pro-Ino Dev Aps | Handheld apparatus for testing a sample of prepared food for allergens and/or food intolerance ingredients |
US11450437B2 (en) | 2015-09-24 | 2022-09-20 | Tencent Technology (Shenzhen) Company Limited | Health management method, apparatus, and system |
CN105445447B (en) * | 2015-09-28 | 2018-03-27 | 腾讯科技(深圳)有限公司 | Measuring method and device based on test paper |
KR102372113B1 (en) | 2016-10-05 | 2022-03-07 | 에프. 호프만-라 로슈 아게 | Detection reagents and electrode arrangements for multi-analyte diagnostic test elements, and methods of using the same |
WO2018161063A1 (en) | 2017-03-03 | 2018-09-07 | Acea Biosciences, Inc. | METHODS AND SYSTEMS FOR FUNCTIONAL MATURATION OF iPSC AND ESC DERIVED CARDIOMYOCYTES |
JP7023159B2 (en) * | 2018-04-02 | 2022-02-21 | 日本特殊陶業株式会社 | Manufacturing method of sensor element, gas sensor and gas sensor |
USD941488S1 (en) | 2020-02-07 | 2022-01-18 | Agilent Technologies, Inc. | Instrument for analyzing biological cells |
EP4285118A1 (en) * | 2021-01-28 | 2023-12-06 | 3M Innovative Properties Company | System and methods for detecting an analyte and transmitting test assay results |
US20230333050A1 (en) * | 2022-04-19 | 2023-10-19 | Lg Electronics Inc. | Biosensor chip and biosensor cartridges having the same |
Family Cites Families (119)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4081653A (en) * | 1976-12-27 | 1978-03-28 | Western Electric Co., Inc. | Removal of thin films from substrates by laser induced explosion |
US4131484A (en) * | 1978-02-13 | 1978-12-26 | Western Electric Company, Inc. | Frequency adjusting a piezoelectric device by lasering |
JPS56100451A (en) | 1980-01-14 | 1981-08-12 | Matsushita Electric Ind Co Ltd | Manufacture of electrode of semiconductor device |
DE3133826A1 (en) | 1981-08-27 | 1983-03-10 | Boehringer Mannheim Gmbh, 6800 Mannheim | ANALYSIS TEST STRIP AND METHOD FOR THE PRODUCTION THEREOF |
US4414059A (en) * | 1982-12-09 | 1983-11-08 | International Business Machines Corporation | Far UV patterning of resist materials |
US5509410A (en) * | 1983-06-06 | 1996-04-23 | Medisense, Inc. | Strip electrode including screen printing of a single layer |
US5682884A (en) * | 1983-05-05 | 1997-11-04 | Medisense, Inc. | Strip electrode with screen printing |
JPS61500508A (en) † | 1983-11-10 | 1986-03-20 | センテツク メデイカル コ−ポレイシヨン | Clinical chemistry analyzer |
EP0149424B1 (en) | 1983-12-19 | 1990-11-14 | GRETAG Aktiengesellschaft | Method and device for determining the quality of prints, and colour test strip for said determination |
US4654127A (en) † | 1984-04-11 | 1987-03-31 | Sentech Medical Corporation | Self-calibrating single-use sensing device for clinical chemistry and method of use |
US4707722A (en) * | 1984-12-17 | 1987-11-17 | Motorola, Inc. | Laser marking method and ablative coating for use therein |
WO1986007632A1 (en) * | 1985-06-21 | 1986-12-31 | Matsushita Electric Industrial Co., Ltd. | Biosensor and method of manufacturing same |
US4865973A (en) * | 1985-09-13 | 1989-09-12 | Queen's University At Kingston | Process for extractive fermentation |
US4714874A (en) | 1985-11-12 | 1987-12-22 | Miles Inc. | Test strip identification and instrument calibration |
US4865873A (en) | 1986-09-15 | 1989-09-12 | General Electric Company | Electroless deposition employing laser-patterned masking layer |
US4874500A (en) * | 1987-07-15 | 1989-10-17 | Sri International | Microelectrochemical sensor and sensor array |
US5200053A (en) † | 1987-11-24 | 1993-04-06 | Terumo Kabushiki Kaisha | Reference electrode |
DE68924026T3 (en) * | 1988-03-31 | 2008-01-10 | Matsushita Electric Industrial Co., Ltd., Kadoma | BIOSENSOR AND ITS MANUFACTURE. |
JPH0761552B2 (en) * | 1989-03-17 | 1995-07-05 | 富士通株式会社 | How to write a barcode |
US5018164A (en) * | 1989-09-12 | 1991-05-21 | Hughes Aircraft Company | Excimer laser ablation method and apparatus for microcircuit fabrication |
US5089103A (en) * | 1989-12-01 | 1992-02-18 | Hewlett-Packard Company | Electrophoresis capillary with agarose |
GB8927377D0 (en) * | 1989-12-04 | 1990-01-31 | Univ Edinburgh | Improvements in and relating to amperometric assays |
US4999582A (en) | 1989-12-15 | 1991-03-12 | Boehringer Mannheim Corp. | Biosensor electrode excitation circuit |
US4963814A (en) | 1989-12-15 | 1990-10-16 | Boehringer Mannheim Corporation | Regulated bifurcated power supply |
US5508171A (en) * | 1989-12-15 | 1996-04-16 | Boehringer Mannheim Corporation | Assay method with enzyme electrode system |
US4999632A (en) | 1989-12-15 | 1991-03-12 | Boehringer Mannheim Corporation | Analog to digital conversion with noise reduction |
US5243516A (en) | 1989-12-15 | 1993-09-07 | Boehringer Mannheim Corporation | Biosensing instrument and method |
KR0171222B1 (en) * | 1989-12-15 | 1999-02-18 | 스티브 올드함 | Redox mediator reagent and biosensor |
US5061341A (en) † | 1990-01-25 | 1991-10-29 | Eastman Kodak Company | Laser-ablating a marking in a coating on plastic articles |
JPH0820412B2 (en) * | 1990-07-20 | 1996-03-04 | 松下電器産業株式会社 | Quantitative analysis method and device using disposable sensor |
US5104480A (en) * | 1990-10-12 | 1992-04-14 | General Electric Company | Direct patterning of metals over a thermally inefficient surface using a laser |
EP0549791B1 (en) * | 1991-04-01 | 1997-07-16 | Aktsionernoe obschestvo otkrytogo tipa VNIIETO | Multilayer printed circuit board and method of manufacture |
JP3118015B2 (en) * | 1991-05-17 | 2000-12-18 | アークレイ株式会社 | Biosensor and separation and quantification method using the same |
US5264103A (en) * | 1991-10-18 | 1993-11-23 | Matsushita Electric Industrial Co., Ltd. | Biosensor and a method for measuring a concentration of a substrate in a sample |
EP0545328B1 (en) * | 1991-11-29 | 1997-03-19 | Hitachi Chemical Co., Ltd. | Printed circuit board manufacturing process |
US5336388A (en) * | 1991-12-26 | 1994-08-09 | Ppg Industries, Inc. | Analyte and pH measuring sensor assembly and method |
JPH05315703A (en) | 1992-05-13 | 1993-11-26 | Sumitomo Electric Ind Ltd | Manufacture of semiconductor laser |
GB9221099D0 (en) * | 1992-10-07 | 1992-11-18 | Ecossensors Ltd | Improvements in and relating to gas permeable membranes for amperometric gas electrodes |
FR2701117B1 (en) * | 1993-02-04 | 1995-03-10 | Asulab Sa | Electrochemical measurement system with multizone sensor, and its application to glucose measurement. |
DE4310106C1 (en) * | 1993-03-27 | 1994-10-06 | Bruker Saxonia Analytik Gmbh | Manufacturing process for switching grids of an ion mobility spectrometer and switching grids manufactured according to the process |
US5390412A (en) * | 1993-04-08 | 1995-02-21 | Gregoire; George D. | Method for making printed circuit boards |
DE59408870D1 (en) | 1993-04-23 | 1999-12-09 | Roche Diagnostics Gmbh | System for stocking and making available test elements |
US5405511A (en) | 1993-06-08 | 1995-04-11 | Boehringer Mannheim Corporation | Biosensing meter with ambient temperature estimation method and system |
US5366609A (en) | 1993-06-08 | 1994-11-22 | Boehringer Mannheim Corporation | Biosensing meter with pluggable memory key |
US5352351A (en) | 1993-06-08 | 1994-10-04 | Boehringer Mannheim Corporation | Biosensing meter with fail/safe procedures to prevent erroneous indications |
EP0702789B8 (en) | 1993-06-08 | 2006-06-14 | Roche Diagnostics Operations, Inc. | Biosensing meter which detects proper electrode engagement and distinguishes sample and check strips |
US5413690A (en) | 1993-07-23 | 1995-05-09 | Boehringer Mannheim Corporation | Potentiometric biosensor and the method of its use |
JPH0760464A (en) * | 1993-08-23 | 1995-03-07 | Namiki Precision Jewel Co Ltd | Laser marking method to transmittable base alloy |
JPH0766499A (en) | 1993-08-25 | 1995-03-10 | Honda Motor Co Ltd | Manufacture of semiconductor laser |
US5589326A (en) * | 1993-12-30 | 1996-12-31 | Boehringer Mannheim Corporation | Osmium-containing redox mediator |
US5762770A (en) | 1994-02-21 | 1998-06-09 | Boehringer Mannheim Corporation | Electrochemical biosensor test strip |
US5437999A (en) * | 1994-02-22 | 1995-08-01 | Boehringer Mannheim Corporation | Electrochemical sensor |
WO1995022881A1 (en) * | 1994-02-22 | 1995-08-24 | Philips Electronics N.V. | Laser etching method |
US5391250A (en) * | 1994-03-15 | 1995-02-21 | Minimed Inc. | Method of fabricating thin film sensors |
JPH07290751A (en) | 1994-04-22 | 1995-11-07 | Matsushita Electric Ind Co Ltd | Powder flying recording apparatus |
DE4417245A1 (en) * | 1994-04-23 | 1995-10-26 | Lpkf Cad Cam Systeme Gmbh | High resolution structured metallisation prodn. |
US5637850A (en) * | 1994-05-03 | 1997-06-10 | Honda; Takaharu | Method of making and reading engraved and oxidation code marks on surgical instruments |
EP0727925A1 (en) * | 1995-02-14 | 1996-08-21 | Lpkf Cad/Cam Systeme Gmbh | Process for structured metallizing of the surface of substrates |
US5567302A (en) * | 1995-06-07 | 1996-10-22 | Molecular Devices Corporation | Electrochemical system for rapid detection of biochemical agents that catalyze a redox potential change |
DE69603931T2 (en) * | 1995-06-27 | 2000-03-30 | Koninkl Philips Electronics Nv | METHOD FOR PRODUCING MULTILAYER ELECTRONIC COMPONENTS |
DE19535068C2 (en) * | 1995-09-21 | 1997-08-21 | Lpkf Cad Cam Systeme Gmbh | Coating for the structured production of conductor tracks on the surface of electrically insulating substrates, method for producing the coating and of structured conductor tracks |
US5628890A (en) * | 1995-09-27 | 1997-05-13 | Medisense, Inc. | Electrochemical sensor |
JPH09207343A (en) * | 1995-11-29 | 1997-08-12 | Matsushita Electric Ind Co Ltd | Laser machining method |
US5755953A (en) * | 1995-12-18 | 1998-05-26 | Abbott Laboratories | Interference free biosensor |
JP3365184B2 (en) † | 1996-01-10 | 2003-01-08 | 松下電器産業株式会社 | Biosensor |
US5989917A (en) | 1996-02-13 | 1999-11-23 | Selfcare, Inc. | Glucose monitor and test strip containers for use in same |
US5708247A (en) * | 1996-02-14 | 1998-01-13 | Selfcare, Inc. | Disposable glucose test strips, and methods and compositions for making same |
JP3100897B2 (en) | 1996-03-26 | 2000-10-23 | 三洋電機株式会社 | Manufacturing method of integrated solar cell device |
GB2311614B (en) | 1996-03-29 | 2000-04-12 | Byk Gulden Italia Spa | Automatic diagnostic apparatus |
GB2322707B (en) * | 1996-06-17 | 2000-07-12 | Mercury Diagnostics Inc | Electrochemical test device and related methods |
US5800690A (en) * | 1996-07-03 | 1998-09-01 | Caliper Technologies Corporation | Variable control of electroosmotic and/or electrophoretic forces within a fluid-containing structure via electrical forces |
JP3510740B2 (en) * | 1996-08-26 | 2004-03-29 | シャープ株式会社 | Manufacturing method of integrated thin-film solar cell |
US5945341A (en) * | 1996-10-21 | 1999-08-31 | Bayer Corporation | System for the optical identification of coding on a diagnostic test strip |
US5856195A (en) | 1996-10-30 | 1999-01-05 | Bayer Corporation | Method and apparatus for calibrating a sensor element |
KR100243656B1 (en) * | 1996-12-05 | 2000-02-01 | 정선종 | A vertical-cavity surface-emitting LASER with hydrogenation treatment and method for fabricating the same |
US5929422A (en) | 1997-04-04 | 1999-07-27 | National Medical Review Office Inc. | On-site Machine readable assaying system |
GB9708585D0 (en) | 1997-04-29 | 1997-06-18 | Eastman Kodak Co | Apparatus, magazine and method for electrochemical detection or measurement |
US5759364A (en) * | 1997-05-02 | 1998-06-02 | Bayer Corporation | Electrochemical biosensor |
US5798031A (en) | 1997-05-12 | 1998-08-25 | Bayer Corporation | Electrochemical biosensor |
JP3702582B2 (en) * | 1997-06-03 | 2005-10-05 | Nok株式会社 | Measuring method using biosensor |
GB9711395D0 (en) * | 1997-06-04 | 1997-07-30 | Environmental Sensors Ltd | Improvements to electrodes for the measurement of analytes in small samples |
US6309526B1 (en) * | 1997-07-10 | 2001-10-30 | Matsushita Electric Industrial Co., Ltd. | Biosensor |
BRPI9816314B1 (en) * | 1997-07-22 | 2017-10-31 | Arkray, Inc. | INSERTION TEST STRIP FOR A CONCENTRATION MEASUREMENT DEVICE |
US6129823A (en) * | 1997-09-05 | 2000-10-10 | Abbott Laboratories | Low volume electrochemical sensor |
FI107080B (en) | 1997-10-27 | 2001-05-31 | Nokia Mobile Phones Ltd | measuring device |
US5997817A (en) | 1997-12-05 | 1999-12-07 | Roche Diagnostics Corporation | Electrochemical biosensor test strip |
US6165594A (en) | 1998-01-15 | 2000-12-26 | 3M Innovative Properties Company | Multilayer, temperature resistant, composite label |
US6394952B1 (en) | 1998-02-03 | 2002-05-28 | Adeza Biomedical Corporation | Point of care diagnostic systems |
US6103033A (en) * | 1998-03-04 | 2000-08-15 | Therasense, Inc. | Process for producing an electrochemical biosensor |
US6134461A (en) * | 1998-03-04 | 2000-10-17 | E. Heller & Company | Electrochemical analyte |
US6175752B1 (en) * | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
JP2000019147A (en) | 1998-07-01 | 2000-01-21 | Nok Corp | Reaction product measuring device |
DE29814997U1 (en) | 1998-08-20 | 1998-12-03 | Lre Technology Partner Gmbh | Test strip measuring system |
US6338790B1 (en) * | 1998-10-08 | 2002-01-15 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
JP2000121594A (en) | 1998-10-15 | 2000-04-28 | Kdk Corp | Biosensor |
EP1135679B1 (en) * | 1998-11-30 | 2009-09-02 | Abbott Laboratories | Multichemistry measuring device and test strips |
AU768312B2 (en) † | 1998-11-30 | 2003-12-11 | Abbott Laboratories | Analyte test instrument having improved calibration and communication processes |
US6203952B1 (en) * | 1999-01-14 | 2001-03-20 | 3M Innovative Properties Company | Imaged article on polymeric substrate |
JP2000212760A (en) * | 1999-01-19 | 2000-08-02 | Hitachi Cable Ltd | Production of partially plated plastic molding |
US6258229B1 (en) | 1999-06-02 | 2001-07-10 | Handani Winarta | Disposable sub-microliter volume sensor and method of making |
US6287451B1 (en) | 1999-06-02 | 2001-09-11 | Handani Winarta | Disposable sensor and method of making |
JP2001087874A (en) * | 1999-09-22 | 2001-04-03 | Miyachi Technos Corp | Method and device for laser beam marking |
US6645359B1 (en) * | 2000-10-06 | 2003-11-11 | Roche Diagnostics Corporation | Biosensor |
US6662439B1 (en) † | 1999-10-04 | 2003-12-16 | Roche Diagnostics Corporation | Laser defined features for patterned laminates and electrodes |
CN100363739C (en) * | 1999-11-15 | 2008-01-23 | 松下电器产业株式会社 | Biosensor, method of forming thin-film electrode, and method and apparatus for quantitative determination |
ATE278946T1 (en) † | 2000-03-22 | 2004-10-15 | All Medicus Co Ltd | ELECTROCHEMICAL BIOSENSOR TEST STRIP WITH DETECTION ELECTRODE AND READER USING THIS TEST STRIP |
US6413213B1 (en) | 2000-04-18 | 2002-07-02 | Roche Diagnostics Corporation | Subscription based monitoring system and method |
US6696008B2 (en) * | 2000-05-25 | 2004-02-24 | Westar Photonics Inc. | Maskless laser beam patterning ablation of multilayered structures with continuous monitoring of ablation |
JP3542999B2 (en) * | 2000-05-29 | 2004-07-14 | 松下電器産業株式会社 | Biosensor and manufacturing method thereof |
ATE279552T1 (en) | 2000-09-26 | 2004-10-15 | Enthone Omi Deutschland Gmbh | METHOD FOR SELECTIVE METALLIZATION OF DIELECTRIC MATERIALS |
US6540890B1 (en) * | 2000-11-01 | 2003-04-01 | Roche Diagnostics Corporation | Biosensor |
JP2002156358A (en) | 2000-11-20 | 2002-05-31 | Matsushita Electric Ind Co Ltd | Biosensor, notification device, and measuring instrument |
EP2388585B1 (en) | 2000-11-30 | 2018-05-02 | Panasonic Healthcare Holdings Co., Ltd. | Method of quantifying substrate |
JP4120400B2 (en) * | 2001-04-16 | 2008-07-16 | 松下電器産業株式会社 | Biosensor |
US7022218B2 (en) * | 2001-05-29 | 2006-04-04 | Matsushita Electric Industrial Co., Ltd. | Biosensor with interdigitated electrodes |
EP1413879B1 (en) | 2001-08-01 | 2012-01-25 | ARKRAY, Inc. | Analyzing instrument, analyzing device |
US6814844B2 (en) | 2001-08-29 | 2004-11-09 | Roche Diagnostics Corporation | Biosensor with code pattern |
CN100476421C (en) | 2001-09-28 | 2009-04-08 | 爱科来株式会社 | Measurement instrument and concentration measurement apparatus |
JP4833512B2 (en) * | 2003-06-24 | 2011-12-07 | 東京エレクトロン株式会社 | To-be-processed object processing apparatus, to-be-processed object processing method, and to-be-processed object conveyance method |
-
2001
- 2001-08-29 US US09/942,515 patent/US6814844B2/en not_active Expired - Lifetime
-
2002
- 2002-08-22 JP JP2002241745A patent/JP4098031B2/en not_active Expired - Lifetime
- 2002-08-27 ES ES02018986.6T patent/ES2367102T5/en not_active Expired - Lifetime
- 2002-08-27 AT AT02018986T patent/ATE511640T1/en not_active IP Right Cessation
- 2002-08-27 EP EP02018986.6A patent/EP1288653B2/en not_active Expired - Lifetime
- 2002-08-27 CA CA002399887A patent/CA2399887C/en not_active Expired - Lifetime
-
2004
- 2004-10-29 US US10/976,740 patent/US7476827B1/en not_active Expired - Lifetime
-
2005
- 2005-06-22 US US11/158,772 patent/US7780827B1/en active Active
-
2007
- 2007-07-17 JP JP2007186179A patent/JP2007309947A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8417545B2 (en) | 2007-02-15 | 2013-04-09 | Abbott Diabetes Care Inc. | Device and method for automatic data acquisition and/or detection |
US8676601B2 (en) | 2007-02-15 | 2014-03-18 | Abbott Diabetes Care Inc. | Device and method for automatic data acquisition and/or detection |
US10022499B2 (en) | 2007-02-15 | 2018-07-17 | Abbott Diabetes Care Inc. | Device and method for automatic data acquisition and/or detection |
Also Published As
Publication number | Publication date |
---|---|
JP4098031B2 (en) | 2008-06-11 |
US7780827B1 (en) | 2010-08-24 |
EP1288653B2 (en) | 2017-11-29 |
US20080314882A1 (en) | 2008-12-25 |
JP2003149192A (en) | 2003-05-21 |
JP2007309947A (en) | 2007-11-29 |
US20100219071A1 (en) | 2010-09-02 |
EP1288653A1 (en) | 2003-03-05 |
US6814844B2 (en) | 2004-11-09 |
ES2367102T3 (en) | 2011-10-28 |
CA2399887A1 (en) | 2003-02-28 |
US7476827B1 (en) | 2009-01-13 |
US20040200721A1 (en) | 2004-10-14 |
ES2367102T5 (en) | 2018-03-01 |
EP1288653B1 (en) | 2011-06-01 |
ATE511640T1 (en) | 2011-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2399887C (en) | Biosensor | |
US6866758B2 (en) | Biosensor | |
CA2387283C (en) | Biosensor | |
CA2407353C (en) | Biosensor | |
US6814843B1 (en) | Biosensor | |
US6767440B1 (en) | Biosensor | |
US6911621B2 (en) | Biosensor | |
CA2357968C (en) | Biosensor | |
CA2547681C (en) | Biosensor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20220829 |